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Edited by Mike ShipstonTrypanosoma brucei is a species of unicellular parasite that
can cause severe diseases in livestock and humans, including
African trypanosomiasis and Chagas disease. Adaptation to
diverse environments and changes in nutritional conditions is
essential for T. brucei to establish an infection when changing
hosts or during invasion of different host tissues. One such
adaptation is the ability of T. brucei to rapidly switch its energy
metabolism from glucose metabolism in the mammalian blood
to proline catabolism in the insect stages and vice versa.
However, the mechanisms that support the parasite’s response
to nutrient availability remain unclear. Using RNAseq and
qRT-PCR, we investigated the response of T. brucei to amino
acid or glucose starvation and found increased mRNA levels of
several amino acid transporters, including all genes of the
amino acid transporter AAT7-B subgroup. Functional charac-
terization revealed that AAT7-B members are plasma
membrane-localized in T. brucei and when expressed in
Saccharomyces cerevisiae supported the uptake of proline,
alanine, and cysteine, while other amino acids were poorly
recognized. All AAT7-B members showed a preference for
proline, which is transported with high or low affinity. RNAi-
mediated AAT7-B downregulation resulted in a reduction of
intracellular proline concentrations and growth arrest under
low proline availability in cultured procyclic form parasites.
Taken together, these results suggest a role of AAT7-B trans-
porters in the response of T. brucei to proline starvation and
proline catabolism.
The pathogenic trypanosomatids Trypanosoma brucei spp.,
Trypanosoma cruzi spp., and Leishmania spp. cause severe
tropical diseases in humans and livestock, such as African
trypanosomiasis, Chagas disease, or leishmaniasis, respectively
(1). The parasitic lifestyle of trypanosomes resulted in a
reduction and streamlining of their genome compared with
related, free-living species of the kinetoplastids (2, 3). It
favored reliance on the salvage of nutrients (4) and resulted,
for example, in the development of amino acid auxotrophies
(3) coupled with expansion of the respective uptake systems
(2). Trypanosomes not only undergo multiple developmental
transitions and linked morphological changes, but also* For correspondence: Doris Rentsch, doris.rentsch@ips.unibe.ch.
© 2021 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for
BY license (http://creativecommons.org/licenses/by/4.0/).encounter diverse environmental conditions in their insect
vector and vertebrate host, to which they adapt by remodeling
their metabolism (5–8).
Amino acids play an important role in the metabolism and
life cycle of T. brucei (reviewed in (9)). Proline is of particular
interest, as proline biosynthesis is absent in T. brucei, making
the parasites dependent on proline uptake for protein synthesis
(8). In its insect host, the tsetse fly, the procyclic form of
T. brucei lives in the midgut. Later developmental stages are
found in the proventriculus and salivary glands (10). In these
stages T. brucei has limited access to glucose and instead relies
on the degradation of amino acids as carbon and energy
sources, among which proline is the most abundant in the
insect’s hemolymph (11, 12).
Proline is used by T. brucei to fuel oxidative phosphory-
lation in the mitochondrion and is the main source of energy
for the insect stages of the parasite (13). Proline metabolism
has been studied extensively (13–20) and is of fundamental
importance for the survival of T. brucei in the tsetse fly (13).
The first two enzymes of proline degradation, proline dehy-
drogenase and Δ1-pyrroline-5-carboxylate dehydrogenase
(P5CDH), are essential for the parasite’s grown in the absence
of glucose in vitro (13, 14), and parasites lacking P5CDH fail
to establish tsetse fly midgut infections in vivo (13). Down-
stream steps involve a partially active tricarboxylic acid
(TCA) cycle and the production of pyruvate from malate.
Pyruvate can be further oxidized to acetyl coenzyme A and
then to acetate, or it can be used as an amino group acceptor
and converted to alanine, which has to be exported from the
mitochondrion and excreted from the cell (16). Alanine is
used as an osmolyte in many trypanosomatids, contributing
to a large portion of the cellular amino acid pool (21), and
was also shown to be a main excretion product in hypo-
osmotic stress responses in Leishmania spp. (22, 23) and
T. cruzi (24).
Because proline degradation is linked to the TCA cycle, it is
interesting that TCA cycle intermediates can initiate the dif-
ferentiation from short stumpy bloodstream forms to procyclic
forms (25). This differentiation can also be triggered by
depriving stumpy forms of glucose, which concomitantly in-
duces upregulation of enzymes involved in proline degradation
(17). Similarly, upregulation of proline metabolism as well as
an increase in proline uptake and consumption was shown inJ. Biol. Chem. (2021) 296 100566 1
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In the tsetse fly, T. brucei has to compete for nutrients,
including proline, which is used by the insect as energy source
for flight muscles (11, 26). Proline availability undergoes high
fluctuations during starvation periods or insect flight (11). In
contrast, in the bloodstream of the mammalian host, nutrients
are readily replenished, and a high availability of glucose allows
the parasite to utilize this sugar as its main energy and carbon
source. T. brucei can not only be found in the bloodstream, but
also in the skin (27), adipose tissue (28) and, during the second
stage of parasitemia, in the cerebrospinal fluid (29), all being
rather poor in nutrients compared with blood (30). Therefore,
T. brucei has to be able to adapt to varying nutritional con-
ditions in the insect and the vertebrate host, both possibly
involving the regulation of amino acid transporters.
While many amino acid transport activities have been
determined using whole trypanosomatids (9), few individual
transporters have been characterized at the molecular level in
T. brucei (31–33). While it was shown that procyclic form
T. brucei upregulates proline transport in the absence of
glucose (14), the transporters involved are still unknown. In
Leishmania the selective proline/alanine transporter LdAAP24
was shown to be essential to fuel the cellular proline pool and
be involved in the response to hypotonic stress (23). The
LdAAP24 homolog in T. cruzi (TcAAAP069) also transports
proline (34). The most closely related transporter in T. brucei,
TbAAT6, was identified as the entry point for eflornithine (32,
35, 36) and also supports uptake of mainly neutral amino acids,
including proline (32), but its involvement in proline meta-
bolism was not tested.
Parasites can respond to amino acid availability. Leish-
mania donovani can sense a reduction in environmental
arginine and reacts by upregulating the high-affinity arginine
transporter LdAAP3 in a mitogen-activated protein kinase-
dependent way (37, 38). High-affinity arginine transporters
have been shown to be essential for T. brucei PCF and blood
stream form (31), but the regulation of these and other amino
acid transporters by nutrient availability in T. brucei has not
been studied so far.
Transcriptome and proteome analyses in T. brucei identified
multiple amino acid transporters that were regulated stage
specifically (25, 39–46). This response may reflect the different
nutritional environments and amino acid availability within
the different host tissues, but also the change in energy
metabolism between the mammalian and the insect life-cycle
stages. We have looked for amino acid transporters whose
transcripts are regulated in response to amino acid starvation,
as might be encountered by trypanosomes in the skin tissue or
the cerebrospinal fluid in the mammal, upon change of host or
during starvation of the tsetse fly. We identified transcripts of
amino acid transporters from three loci that were upregulated
upon nutrient starvation. Further characterization of three of
these genes belonging to the amino acid transporter 7 family
(AAT7, (47)) showed that they encode high and low-affinity
proline transporters that are essential in T. brucei procyclic
form under proline limitation.2 J. Biol. Chem. (2021) 296 100566Results
Amino acid transporters of the T. brucei AAT7 locus are
upregulated in response to amino acid or glucose starvation
To test whether amino acid deprivation has an impact on
transcript levels of amino acid transporters, we performed
transcriptome analyses of T. brucei under different starvation
conditions. For this purpose we prepared modified culture
media that allowed us to assess the response to amino acid
starvation in both procyclic form and bloodstream form (BSF)
T. brucei and the response to glucose starvation in PCF. For
these experiments we used 29-13 (Lister 427 procyclic form,
(48)) cultivated in commercial SDM79 (including 10% FBS)
(49). To start starvation, SDM79 was replaced by different
formulations of our home-made starvation medium, SDM79S,
which closely resembles the formulation of SDM79, but lacks
FBS (for composition see Table 1 and for details Table S1). As
a control, fresh commercial SDM79 (+10% FBS) was used.
Starvation media contained glucose and all amino acids
(SDM79S+AA, i.e., control for lack of FBS), glucose but no
amino acids (SDM79S-AA), or lacked glucose, but contained
all amino acids and 50 mM N-acetyl glucosamine (GlcNAc) to
reduce uptake of residual glucose (SDM79S-G). A similar
experimental setup was chosen for starvation of bloodstream
form NY-SM cells (48). Cells were first cultured in HMI-11
(containing 10% (v/v) FBS, based on commercial IMDM)
(50) and then incubated either in fresh HMI-11 or starvation
medium HMIS (for composition see Tables 1 and S1) con-
taining all amino acids but no FBS (HMIS+AA) or in HMIS
containing no amino acids and no FBS (HMIS-AA). After the
starvation period, RNA was extracted and submitted for RNA
sequencing (RNA-seq) and mapped to the genome of T. brucei
Lister 427_2018 (51). RNA-seq resulted in at least 20 million
reads per sample and could be mapped with an efficiency of
>80% to the reference genome. For comparative tran-
scriptome analysis, reads were mapped to the annotated cod-
ing sequences of T. brucei Lister 427_2018, which accounted
for 34–47% of all reads, i.e., ≥ nine million reads per sample.
Mapped reads per gene were normalized to the total number
of mapped reads per sample to obtain RPM (reads per million)
values but were not normalized to the length of the transcript.
We could identify mapped reads of approximately 14,400
genes, from which we removed all pseudogenes genes and
genes with less than 100 mapped reads within the coding re-
gion of the gene, leaving around 8200 genes for PCF data and
8600 genes for the BSF data. Data of two independent bio-
logical replicates are shown (Tables 2 and S2).
In amino-acid-starved PCF among the ten most highly
upregulated transcripts, we found four amino acid transporters
that showed more than 4-fold upregulation after 6 h starvation,
compared with cells grown with amino acids (Tables 2 and S2).
Three of the genes (Tb927.8.7610/7630/7640; 427_2018 does
not contain a gene copy of Tb927.8.7620) belong to the amino
acid transporter AAT7 locus (47). Additionally, the amino acid
transporter Tb927.11.15960 (AAT17.2) showed a similar in-
crease in expression. Messenger RNA levels of all these



















































































































































































































































































































































































































































































































































































































EDITORS’ PICK: Proline/alanine transporters in T. bruceiamino acids than in medium lacking glucose (Table 2). The
RNA-seq data further showed a small effect on the transcript
levels of the ornithine transporter Tb927.8.8290 (AAT10.1,
(33)), one additional gene of the AAT7 locus (Tb927.8.7650),
and also a minor effect on the putative amino acid transporter
Tb927.8.8300. Transcript levels of AAT6 (Tb927.8.5450) that
was previously reported to transport neutral amino acids
including proline (32), or the arginine transporter
Tb927.8.4710 (AAT5.2, (31)), and other putative amino acid
transporters were either not altered or not upregulated
(Tables 2 and S2).
To validate the RNA-seq results, expression of selected
amino acid transporters, which were upregulated
(Tb927.8.7610/30/40, Tb927.11.15960), slightly altered
(Tb927.8.8290, Tb927.8.8300), or not affected (Tb927.8.4710
and Tb927.8.5450) by starvation, was verified in an indepen-
dent experiment by qRT-PCR using telomerase reverse tran-
scriptase (TERT, Tb927.11.10190) as a reference gene. By
using a single primer for the three genes Tb927.8.7610/30/40,
we further could confirm higher transcript levels when cells
were depleted of either amino acids or glucose, compared with
control conditions where both compounds were present. To
better describe time dependence of transcript upregulation,
three time points (2 h, 4 h, and 6 h), were used for the qRT-
PCR analyses. While a time dependence of Tb927.8.7610/30/
40 mRNA levels was observed in the RNA-seq experiments,
this could not be seen in the experiments analyzed by qRT-
PCR (Fig. 1A). We further confirmed the high upregulation
of the putative amino acid transporter Tb927.11.15960 upon
deprivation of amino acids or glucose (Fig. 1B). The ornithine
transporter Tb927.8.8290 showed a less pronounced upregu-
lation under amino acid starvation in the qRT-PCR analysis
(Fig. S1A), but still a general trend for upregulation in starved
compared with nonstarved cells (Table 2). Similarly, the
changes during deprivation of amino acids and glucose star-
vation observed for Tb927.8.8300 were not as pronounced
using qRT-PCR compared with RNA-seq and were mostly
seen during later time points of starvation (6 h). Moreover, we
also observed reduced Tb927.8.8300 transcript levels in me-
dium lacking FBS (Fig. S1B). The other transporters analyzed
by qRT-PCR i.e., the arginine transporters of the AAT5 locus
(Tb927.8.4710, Tb927.8.4720, Tb927.8.4730, Tb927.8.4740,
and Tb927.8.4750, (31)) were slightly upregulated upon
glucose depletion, although the measurements showed strong
variability (Fig. S1C), while the neutral amino acid transporter
AAT6 (Tb927.8.5450) (32) showed no significant changes in
expression upon deprivation of glucose or amino acids
(Fig. S1D). The lack of FBS in all formulations of the starvation
media caused only minor changes to amino acid transporter
expression within the timeframe of the experiment (Table 2,
Fig. 1 and Table S2).
Having seen that the transcripts of the AAT7-B transporter
(Tb927.8.7610/30/40) become upregulated during amino acid
starvation, we tested if the upregulation could be attributed
specifically to starvation for a single amino acid. Of particular
interest was proline due to its role as energy source in the
insect stages of T. brucei. We tested if upregulation was due toJ. Biol. Chem. (2021) 296 100566 3
Table 2
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Tb427_080082100 Tb927.8.7640 AAT7.5 amino acid transporter 1, putave 1.34 1.89 4.24 5.13 9.74 12.17 8.43 2.58
Tb427_110178500 Tb927.11.15960 AAT17.2 amino acid transporter, putave 0.76 1.93 3.93 8.23 8.85 10.67 9.09 4.98
Tb427_080082000 Tb927.8.7630 AAT7.4 amino acid transporter 1, putave 0.98 1.44 3.94 8.23 8.34 10.07 5.03 2.07
Tb427_080081900 Tb927.8.7610 AAT7.2 amino acid transporter 1, putave 0.93 1.18 2.59 5.27 5.45 5.95 3.95 1.66
Tb427_080088400 Tb927.8.8290 AAT10.1 ornithine transporter, (33) 0.51 0.93 1.37 3.21 1.98 4.03 1.37 1.09
Tb427_080082200 Tb927.8.7650 AAT7.6 amino acid transporter, putave 0.73 0.97 1.55 2.63 2.26 2.59 1.43 1.19
Tb427_080088500 Tb927.8.8300 AAT10.2 amino acid transporter, putave 0.69 0.85 1.65 1.93 2.69 1.78 1.17 1.32
Tb427_080059900 Tb927.8.5450 AAT6 eflornithine / neutral amino acid transporter, (32)(36) 1.26 1.30 1.02 1.72 0.94 1.24 1.04 1.07
Tb427_080052200 Tb927.8.4710 AAT5.2 arginine transporter, (31) 0.60 0.78 0.92 0.81 1.01 0.62 0.74 1.02
Proline metabolism and involved TCA cycle enzymes
Tb427_070005700 Tb927.7.210 PRODH proline dehydrogenase, mitochondrial 0.97 1.18 0.94 1.45 1.00 1.78 1.81 2.80
Tb427_100037100 Tb927.10.3210 P5CDH delta-1-pyrroline-5-carboxylate dehydrogenase, putave 0.75 1.21 0.76 1.06 0.70 1.54 1.42 2.93
Tb427_090032300 Tb927.9.5900 GDH glutamate dehydrogenase 0.55 1.12 0.89 1.33 1.03 1.65 1.62 2.84
Tb427_010027700 Tb927.1.3950 ALAT alanine aminotransferase 0.64 1.18 1.72 1.89 2.51 1.69 2.03 1.23
Tb427_110019000 Tb927.11.1450 OGDH1A 2-oxoglutarate dehydrogenase E1 component, putave 0.67 0.88 1.11 1.19 1.24 1.42 1.20 1.59
Tb427_110108200 Tb927.11.9980 OGDH1B 2-oxoglutarate dehydrogenase E1 component, putave 0.60 1.00 0.80 0.89 0.86 1.36 1.22 1.76
Tb427_110133300 Tb927.11.11680 OGDH2 2-oxoglutarate dehydrogenase E2 component, putave 0.65 1.16 0.98 1.05 0.92 1.18 1.25 1.92
Tb427_030022000 Tb927.3.2230 SCSα succinyl-CoA synthetase alpha subunit, putave 0.92 1.02 0.56 0.47 0.36 0.56 0.89 1.19
Tb427_100080100 Tb927.10.7410 SCSβ succinyl-CoA ligase [GDP-forming] beta-chain, putave 0.69 1.05 0.51 0.51 0.28 0.44 0.88 1.38
Tb427_080072100 Tb927.8.6580 SDH1 succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial 0.61 1.16 1.81 2.21 4.06 2.43 2.98 1.94
Tb427_110055600 Tb927.11.5050 FHm fumarate hydratase, class I 0.71 1.08 0.92 1.00 1.21 1.18 1.33 1.43
Tb427_110059600 Tb927.11.5450 mME malic enzyme 0.73 1.01 0.87 0.96 0.91 1.10 1.03 1.05
TCA cycle enzymes, extended
Tb427_100142000 Tb927.10.13430 CS citrate synthase, putave 0.58 1.63 2.57 2.22 3.85 4.22 5.40 3.28
Tb427_100148200 Tb927.10.14000 ACO aconitase 0.71 1.36 1.50 1.52 2.23 2.26 3.25 2.37
Tb427_080041900 Tb927.8.3690 mIDH isocitrate dehydrogenase [NADP], mitochondrial precursor, putave 0.55 1.02 0.93 0.93 1.07 1.07 1.09 1.14
Tb427_100029900 Tb927.10.2560 mMDH mitochondrial malate dehydrogenase 0.73 0.97 0.98 1.18 0.87 1.83 1.51 1.95
Tb427_100041100 Tb927.10.3650 FRDm1 NADH-dependent fumarate reductase 0.77 0.83 0.58 0.71 0.59 0.53 0.67 0.97
Tb427_110013700 Tb927.11.900 gIDH isocitrate dehydrogenase, putave (glycosomal) 1.08 1.32 2.05 2.85 3.57 3.42 6.12 2.45
Selected transporters and enzymes upregulated in the absence of amino acids or glucose. Amino acid transporters of unknown and known (Tb927.8.8290, (33); Tb927.8.5450, (32); Tb927.8.4710, (31)) function, enzymes involved in proline
catabolism, and enzymes of the TCA cycle not involved in proline metabolism. The table shows the fold change of mRNA levels between cells starved (2 h or 6 h) for amino acids (−AA) or glucose (−G) and nonstarved (+AA) PCF cells, for
two biological replicates (I & II). The effect of FBS is shown by comparing cells grown in SDM79 + 10%FBS (FBS) with cells grown in starvation medium SDM79S including amino acids and glucose, but no FBS (+AA), i.e., FBS/+AA. Red
shading indicates downregulation and green shading upregulation. For each 427_2018 gene identified we matched the corresponding syntenic 927 gene, if possible, and included the gene name and product description for convenience. For




















Figure 1. qRT-PCR analysis of starved PCF. qRT-PCR analysis of amino acid transporter expression of T. brucei 29-13 starved for 2 h (dark gray), 4 h
(medium gray), or 6 h (light gray) of glucose (G), amino acids (AA) or proline (P). y-Axis shows the expression of (A) Tb927.8.7610/30/40 or (B)
Tb927.11.15960s, relative to the reference gene TERT. Media composition as described in Table 1 and Table S1. FBS, commercial SDM79 + 10%FBS; +AA,
starvation medium SDM79S containing amino acids and glucose, but no FBS; −AA, starvation medium SDM79S containing glucose, but no amino acids and
no FBS, −G; starvation medium SDM79S containing amino acids, but no glucose and no FBS; −P, starvation medium SDM79S containing amino acids and
glucose, but no proline and no FBS; −AA+P, starvation medium SDM79S containing glucose and proline, but no other amino acids. Bars show the average of
three independent experiments, error bars represent SD, black dots show individual data points.
EDITORS’ PICK: Proline/alanine transporters in T. bruceithe need for proline or if other amino acids had the same ef-
fect. Analysis of RNA extracted from cells starved for proline
(SDM79S-P) showed increased expression of the
Tb927.8.7610/30/40 transcripts, but we also observed upre-
gulation if cells were starved of all other amino acids except
proline (SDM79S-AA+P, Fig. 1A). Transcript levels of
Tb927.11.15960, which were highly upregulated upon depri-
vation of amino acids or glucose, were also high when only
proline was omitted form the medium. When all other amino
acids were removed, but proline was present, Tb927.11.15960
induction was much lower, indicating a selective response to
proline (Fig. 1B). We also tested other amino acid transporters
for a selective response to proline deprivation, but found no
significant response (Fig. S1).
Proline is the major energy source of T. brucei in the tsetse
fly, and cultured procyclic forms may switch to proline
degradation coupled to oxidative phosphorylation upon
depletion of glucose (14). We therefore also looked at enzymes
involved in proline catabolism and the TCA cycle (Tables 2
and S2) and summarized the results visually (Fig. 2). The
first three enzymes involved in proline degradation, i.e.,
mitochondrial proline dehydrogenase, proline degradation,
proline dehydrogenase (Tb927.7.210), Δ1-pyrroline-5-
carboxylate dehydrogenase, P5CDH (Tb927.10.3210), and
glutamate dehydrogenase, GDH (Tb927.9.5900), showed
slightly higher expression when cells were depleted of glucose.
We also saw upregulation of alanine amino transferase, ALAT
(Tb927.1.3950), members of the 2-oxoglutarate dehydrogenase
complex, ODGC (e.g., OGDH1A, Tb927.11.1450), and mem-
bers of the succinate dehydrogenase complex, SDHC (e.g.,
SDH1, Tb927.8.6580) during starvation. Although we saw
upregulation of ODGC and SDH, succinyl-CoA-synthetase,
SCS (e.g., SCSα, Tb927.3.2230), was downregulated upon
amino acid starvation. Two other steps of proline metabolism
catalyzed by mitochondrial fumarate hydratase (FHm,
Tb927.11.5050) and mitochondrial malic enzyme (mME,
Tb927.11.5450) did not show regulation at the mRNA level
(Tables 2 and S2, Fig. 2).Interestingly, two additional proteins of the TCA cycle,
citrate synthase, CS (Tb927.10.13430) and aconitase, ACO
(Tb927.10.14000), also showed higher expression during
glucose and amino acid starvation. In addition, a strong
upregulation of glycosomal isocitrate hydrogenase (gIDH,
Tb927.11.900) mRNA was detected. While most of the en-
zymes for proline metabolism and the TCA cycle upregulated
most strongly during glucose starvation, succinate dehydro-
genase, citrate synthase, aconitase, and glycosomal isocitrate
dehydrogenase also showed strong upregulation during amino
acid starvation (Tables 2 and S2, Fig. 2).
We also looked at the effect of amino starvation on blood-
stream form in a similar setup, but the RNA-seq data were very
variable between experiments and therefore inconclusive
(Table S2). The effect of amino acid starvation on BSF was also
tested by qRT-PCR analysis for the same amino acid transporters
as for the procyclic form. In addition, the effect of glucose star-
vation on BSF cells was assessed using starvation medium con-
taining all amino acids but no glucose (HMIS-G). Both glucose
starvation and amino acid starvation resulted in a reduction of
Tb927.8.8290 and AAT6 mRNAs (Fig. S2, C and F). For
Tb927.8.7610/30/40, Tb927.8.11.15960, and Tb927.8.8300, we
could also observe a reduction in mRNA upon prolonged amino
acid starvation (Fig. S2, B and D). Tb927.8.4710-50 (AAT5)
transcripts analyzed by qRT-PCR showed no changes during
starvation (Fig. S2).The starvation-induced amino acid transporter genes of the
AAT7 locus belong to the same clade
Of the genes strongly upregulated during starvation, we
further characterized the transporters belonging to the AAT7
family. In T. brucei TREU 927 the AAT7 locus contains 11
putative amino acid transporter genes, of which two are
pseudogenes (i.e., Tb927.8.7660 and Tb927.8.7690). The
remaining nine transporters can be phylogenetically divided
into three subgroups, AAT7-A comprising Tb927.8.7600,
Tb927.8.7650, and Tb927.8.7670; AAT7-B comprisingJ. Biol. Chem. (2021) 296 100566 5
Figure 2. Overview of metabolic genes regulated in starved T. brucei PCF. The scheme shows enzymes and transporters regulated in PCF cells starved
of (A) amino acids or (B) glucose. Blue arrows show pathways involved in proline metabolism. Enzymes (in bubbles) and amino acid transporters (AATs, apple
shape) are color coded according to Table 2. Color is intermediate of replicates I and II after 6 h of starvation. Transporter: AAT10.1, ornithine transporter
Tb927.8.8290; AAT17.2, uncharacterized transporter Tb927.11.15960, AAT7-B, proline transporter Tb927.8.7610, Tb927.8.7630, Tb927.8.7640 (from left to
right). ACO, aconitase; ALAT, alanine aminotransferase; Cit, citrate; CS, citrate synthase; FHm, mitochondrial fumarate hydratase; FRD, NADH-dependent
fumarate reductase; GDH, glutamate dehydrogenase; gIDH, glycosomal isocitrate dehydrogenase; GluSA, glutamate-5-semialdehyde; 2Keto, 2-
ketoglutarate; IsoCit, isocitrate; mIDH, mitochondrial isocitrate dehydrogenase; mMDH, mitochondrial malate dehydrogenase; mME, mitochondrial malic
enzyme; ODGC, 2-oxoglutarate dehydrogenase complex; OxaAc, oxaloacetate; P5C, pyrroline-5-carboxylate; P5CDH, pyrroline-5-carboxylate dehydrogenase;
PRODH, proline dehydrogenase; SCS, succinyl-coenzyme A synthetase; Suc, succinate; SucCoA, succinyl-coenzyme A; SDH1, succinate dehydrogenase.
EDITORS’ PICK: Proline/alanine transporters in T. bruceiTb927.8.7610, Tb927.8.7620, Tb927.8.7630, and Tb927.8.7640;
and AAT7-C, which is phylogenetically more distantly related
and comprises Tb927.8.7680 and Tb927.8.7700 (Fig. 3, (47)).
The genes of T. brucei TREU 927 are syntenic with genes in
the previous database version of the genome of T. brucei.Figure 3. Genes of the AAT7 locus are differentially expressed in PCF and B
for PCF cells grown for 6 h in SDM79 + 10% FBS or BSF cells grown in HMI-11. Lo
CDS for T. brucei Lister 427_2018 (51) or T. brucei TREU 927, with connection of
for AAT7-B and blue for AAT7-C. Genes are abbreviated with the last four dig
6 J. Biol. Chem. (2021) 296 100566Lister 427 strain (Lister 427_2010, sequences obtained from
TriTrypDB, version 46 (52)). The recent de nozvo assembly of
the T. brucei. Lister 427 genome (referred to as Lister
427_2018) using PacBio single molecule sequencing revealed a
novel architecture of the AAT7 locus, including moreSF. Upper panel shows the mapping coverage from an RNAseq experiments
wer panel shows the architecture of the AAT7 locus using the position of the
syntenic genes. AAT7 subgroup are color coded with red for AAT7-A, green
its of their TriTrypDB GeneID.
EDITORS’ PICK: Proline/alanine transporters in T. bruceipseudogenes, but only three genes for the AAT7-B group
(Fig. 3, (51)). During the amplification of the AAT7-B trans-
porter genes, we found multiple SNPs between the genes
amplified from genomic DNA of our T. brucei. Lister 427
strain and the sequences listed in the TriTrypDB database. A
summary of all nucleotide and amino acid changes between
the amplified sequences of our lab strain, sequences used in
this study, and the database sequences (TREU 927, Lister
427_2010, Lister 427_2018; TriTrypDB, version 46 (52)) can be
found in Table S3. Work using the cloned syntenic 427 genes
for Tb927.8.7610, Tb927.8.7620, Tb927.8.7630, and
Tb927.8.7640 will be designated as 7610, 7620, 7630, and 7640,
respectively, whenever used.
Phylogenetically the AAT7 loci A and B group together with
the T. brucei AAT4, AAT10, and AAT2 loci. These loci
encode 23 amino acid transporters, which have no close ho-
mologs in Leishmania major and which branch with a single
amino acid transporter of T. cruzi (2). The AAT7 locus itself
might have undergone concerted evolution within T. b. brucei,
T. b. gambiense, and Trypanosoma congolense. While
T. b. gambiense still has homologs within the AAT7 subgroups
A, B, and C, the AAT7 transporters of T. congolense form a
group of 11 transporters separate from the TbAAT7 sub-
groups A and B and another separate group of three trans-
porters to TbAAT7-C (47).
Tb927.8.7610, Tb927.8.7620, Tb927.8.7630, and
Tb927.8.7640 transport proline, alanine, and cysteine when
expressed in Saccharomyces cerevisiae
Expression in different amino acid transport mutants of
S. cerevisiae and growth under selective conditions revealed
that 7620, 7630, and 7640 supported growth on proline and
cysteine while growth on valine was very poor. (Figs. 4 and S3).
7610 complemented growth on cysteine, but showed no
growth on proline (Figs. 4 and S3). None of these transporters
supported growth on any of the other amino acids tested (see
Experimental proocedures and Fig. S3). In contrast,
Tb927.11.15960 (AAT17.2) was not able to support growth on
any substrate tested so far (not shown).
To characterize transport properties in more detail, we
measured uptake of radiolabeled cysteine in S. cerevisiaeFigure 4. AAT7-B transporters mediate uptake of proline. Expression of the
and growth on M.am medium containing 1 g L−1 proline (Pro) for 4 days and on
for 3 days. As control mutant 22574d transformed with the expression vector (p
to the sequences described in Table S3.mutant Y01543. Because this strain only lacks the high-affinity
cysteine uptake system, cysteine uptake at higher concentra-
tions is rather high, preventing accurate determination of
transport rates of the T. brucei transporters (not shown).
Therefore, transport of proline in S. cerevisiae mutant 22574d
expressing the ORF of 7610, 7620, 7630, or 7640 was tested.
7620, 7630, and 7640 mediated linear time-dependent proline
uptake over the time course of 5 min (Fig. S4). However, for
S. cerevisiae cells expressing 7610, we observed a decline in
proline uptake (Fig. S4), and therefore measurements for this
transporter were reduced to shorter times (up to 1.25 min),
within which uptake of proline was linear. Transport assays at
pH values between pH 4.5 and pH 7.5 showed that 7610 is
functional over the entire pH range with a decrease in uptake
rates at acidic pH compared with neutral pH (Fig. 5A). 7640
showed a stronger reduction in uptake toward acidic pH,
which made measurements at low pH unreliable (Fig. S5). Both
transporters exhibited maximal proline uptake rates around
pH 7.0 (Figs. 5A and S5), which was used for all further
transport assays.
By measuring the initial uptake rates at different concen-
trations of proline, we found a Km of 17.6 ± 3.9 μM (mean ±
SD, n = 4) for 7610 (Fig. 5B). Similar experiments conducted to
estimate the affinity of 7620, 7630, or 7640 indicated sub-
stantially higher Km values of 600 μM, 1000 μM, and 700 μM,
respectively (Fig. S6).
To identify other potential substrates, competition experi-
ments were performed by measuring uptake of radiolabeled
proline in the presence of an excess of all proteinogenic amino
acids and some amino acid analogs. For 7610, only alanine and
cysteine showed strong inhibition of proline uptake, but we
also observed slight inhibition with D-proline, α-amino butyric
acid, homoserine, and glycine (Fig. 5C). The inhibition by
cysteine is supported by the ability to complement growth of a
S. cerevisiaemutant deficient in cysteine uptake (Fig. S3); while
alanine was not tested in growth assays. An independent
experiment in which we measured uptake of radiolabeled
alanine by S. cerevisiae mutant YDR544 expressing 7610
confirmed that alanine enters the yeast cells (Fig. S7). The Km
of alanine estimated from the competition for proline uptakegenes coding for 7610, 7620, 7630, and 7640 in S. cerevisiae mutant 22574d
nonselective minimal medium containing 5 g L−1 ammonium sulfate (NH4
+)
DR197) is shown. The overexpressed ORFs of the AAT7-B group correspond




Figure 5. 7610 is a high-affinity proline and alanine transporter. Uptake rates of L-[3H]-proline were determined using S. cerevisiae mutant 22574d
expressing 7610. A, uptake rates of 100 μM proline at different pH values. Uptake rates are shown relative to the uptake rate at pH 7 (mean ± SD, n = 3). B,
proline transport kinetics. Datapoints are means of at least three independent experiments (mean ± SD, n ≥ 3). Michaelis–Menten constant is the average of
Km values of independent experiments (mean ± SD, n = 4). C, uptake of 100 μM proline in the presence of different amino acids and amino acids analogs at
a 10× excess (1 mM). Uptake rates are shown relative to the uncompeted proline uptake rates (−) set to 100% (mean ± SD, n = 3; 100% correspond to
6.4–7.5 nmol min−1 108 cells−1). Common L-amino acids are abbreviated with their three-letter code, other substances are D-proline (D-Pro), α-amino butyric
acid (AABA), homoserine (Hse), ornithine (Orn), citrulline (Cit), and homocysteine (Hcy). Bars show the average of three independent experiments, error bars
represent SD, black dots show individual data points.
EDITORS’ PICK: Proline/alanine transporters in T. brucei(48 μM) is comparable to the affinity determined in alanine
transport assays (58 μM). Competition experiments, using
S. cerevisiae expressing 7620, 7630, and 7640, indicated a
comparable substrate specificity, with proline being the best
substrate, followed by alanine and cysteine, while the ability of
homocysteine to compete for proline uptake was more variable
(Fig. S8, A–C, n = 1).
7610 and 7640 localize to the plasma membrane
Proline is required in the cytosol and mitochondrion for
protein synthesis. In procyclic forms, mitochondrial proline is
also important for energy metabolism. In-silico analysis
showed no predicted targeting sequence for mitochondria or
other signal peptides (MitoProt (53), MitoFates (54), TargetP
2.0 (55), SignalP 5.0 (56)) for any protein of the AAT7-B locus,
while subcellular localization predictions suggested localiza-
tion at the plasma membrane (57). The proteins are absent
from the published glycosomal (58) and mitochondrial pro-
teomes (59), but were also not identified in a T. brucei cell
surface proteome (60). Members of the AAT7 locus were
found in the membrane proteome of the trypanosome flagel-
lum (61) and in a proteome of whole flagella (62), but the8 J. Biol. Chem. (2021) 296 100566studies could not differentiate between proteins of the AAT7-
A or AAT7-B subfamilies. Only one peptide unique for either
7610 or 7640 was identified (62). TrypTag showed C- and N-
terminal in situ tagging of Tb927.8.7610 fused to mNeon-
Green; however, due to the similarity between the genes it is
not clear which of the AAT7-B gene copies was tagged (63). In
this study tagging of the proteins at the N-terminus resulted in
localization at the pellicular plasma membrane, while C-
terminally tagged proteins exclusively localized at the flagellar
pocket. It is possible, however, that the two localizations
represent the tagging of two different proteins of the AAT7-B
locus (63).
To independently determine the subcellular localization
with a smaller tag, we overexpressed 7610 and 7640 fused to an
N-terminal cMyc tag in procyclic T. brucei cells, to allow
histological staining on fixed cells for confocal microscopy.
The immunofluorescence assays showed localization at the
plasma membrane and partial colocalization with the plasma
membrane glycoprotein marker EP procyclin (Fig. 6). We only
observed a faint signal at the flagellar pocket. Localization at
the plasma membrane allows the transporter to mediate up-
take of proline from the environment into the cytosol of the
Figure 6. 7610 and 7640 are localized at the pellicular membrane. PCF
29-13 cells expressing N-terminally cMyc tagged 7610 and 7640 were
immunodecorated with α-cMyc antibody (red) and α-EP-procylin (green) and
visualized by confocal microscopy. DAPI (blue), brightfield (gray), scale bar
10 μm.
EDITORS’ PICK: Proline/alanine transporters in T. bruceiparasite and supports cellular uptake in parasites and
S. cerevisiae.
Proteins encoded by the AAT7-B locus are involved in proline
uptake in T. brucei and indispensable under conditions of
proline deficiency in PCF
To test whether the transporters are required to maintain
viability of PCF T. brucei, we used RNA interference (RNAi) to
simultaneously downregulate expression of all three AAT7-B
genes. Growth in standard SDM79 medium did not result in
a growth defect between induced and noninduced RNAi cells
(Fig. 7A). The efficiency of mRNA downregulation after 3 days
of RNAi induction was assessed by RT-qPCR using a common
primer pair and showed 80% (±20%) reduction (Fig. 7A, inset).
At this time point, levels of most intracellular free amino acids
remained unaffected with the exception of proline, which
showed 20% reduction in induced RNAi cells (Fig. 7B and
Fig. S10A). To determine if downregulation of AAT7-B is
compensated by increased expression of other amino acid
transporters, we checked transcript levels of Tb927.11.15960
(AAT17.2), Tb927.8.8290 (AAT10.1), Tb927.8.8300
(AAT10.2), and Tb927.8.5450 (AAT6), but found that none of
them was significantly affected (Fig. S9).
As procyclic forms have limited access to glucose in vivo,
the performance of the RNAi cell lines was tested under low
glucose conditions. For this we used the medium prepared for
the starvation experiment and supplemented it with 10% (v/v)
heat-inactivated FBS and glucose or GlcNAc. After adaptation
of the cells to the new medium (see Materials and Methods),
cells grown in SDM79S+AA (supplemented with 10% FBS,
10.8 mM glucose, and lacking GlcNAc) showed a slightly faster
growth rate (doubling time 13 h) than cells grown in com-
mercial SDM79 (doubling time 17 h) and showed no
apparent growth phenotype upon RNAi induction (Fig. 7C).
The RNAi efficiency was similar, >90% reduction of mRNAafter 3 days of tetracycline addition, no change in the tran-
script level of other amino acid transporters (Fig. S9), and
20% reduction in intracellular proline levels was detected
(Figs. 7D and S10B).
When cells were adapted to low glucose conditions
(SDM79S-G, containing 10% (v/v) FBS and 50 mM GlcNAc),
growth was slightly reduced (doubling time 17 h) compared
with growth in SDM79S+AA with glucose, but comparable to
commercial SDM79 (Fig. 7, A and C). Although cells grown in
SDM79S-G medium must have an increased demand for
proline uptake, a knock down did not result in a growth
phenotype (Fig. 7C). The intracellular proline content was
decreased by 66%, from 7.2 mM down to 2.4 mM (Fig. 7D),
assuming a cell volume of 3.31 μl per 108 cells for procyclic
form cells (64). Furthermore, there was a decrease in intra-
cellular levels of aspartate (19%) and glutamate (27%) and an
increase in methionine (32%) and valine, leucine, and isoleu-
cine (18%) (Fig. S10).
To further challenge the cells and test for proline auxot-
rophy reported by previous studies (13, 14), we tested growth
under conditions of reduced proline. The main source of
proline in SDM79 can easily be modified while proline added
through FBS was kept constant and was estimated to ac-
count for 130 μM proline in the final medium (30, 65).
Omitting proline and glucose and growing cells in SDM79S
with 10% FBS and 50 mM GlcNAc (SDM79S-G-P) led to
growth arrest 6 days after transfer to this medium (n = 1,
Fig. S11). This confirmed proline auxotrophy in low glucose
conditions but did not allow us to study the role of the
proline transporters.
To enable stable growth, the addition of 530 μM proline was
required, corresponding to 10% of proline present in standard
SDM79 (named SDM79S-G+0.1P). This medium supported
stable cell growth for at least 4 weeks; longer periods were not
tested. In AAT7-B RNAi cells stably growing in SDM79S-
G+0.1P, we found 500 μM proline, which is already five times
lower than during downregulation of AAT7-B in cells grown in
SDM79S-G (Fig. 7, E and F). Knock-down of the proline trans-
porters under these conditions further decreased internal proline
to 90 μM after 3 days of RNAi induction (Fig. 7F), accompanied
by a growth defect starting on day 5 (Fig. 7E). Further changes
were a decrease in the levels of Asp and Glu by 25% and 32%,
respectively, increases inVal, Leu and Ile by 16–18%, and a strong
increase in methionine levels by 78% (Fig. S10).
We further tested the requirements for proline under con-
ditions where it is not needed for energy production. To date,
no additional function for proline, other than protein synthe-
sis, is known when glucose is present. It was shown previously
that log-phase PCF grown in SDM80 containing both glucose
and proline has a proline consumption rate of approximately
30–50 pmol min−1 106 cells−1 (14), which would correspond to
1–2% of the proline provided by SDM79. We prepared
SDM79S containing 10.8 mM glucose, no proline, and sup-
plemented it with 10% (v/v) FBS (SDM79S-P), which should
result in a final proline concentration of approximately
130 μM. Noninduced RNAi cells adapted to this medium




Figure 7. AAT7-B RNAi in PCF T. brucei impacts cellular proline pools while growth is reduced only under low proline availability. A, growth curve in
standard SDM79 ± Tet. B, intracellular proline concentration in cells grown for 3 days in SDM79 ± Tet as described below. C, growth curves of AAT7-B RNAi
cells grown in starvation medium SDM79S either containing glucose (SDM79S+AA, -) or low glucose (SDM79S-G, ○), ± Tet. D, intracellular proline con-
centrations after 3 days of growth in SDM79S or SDM79S-G, ± Tet. E, growth curves of AAT7-B RNAi cells grown in starvation medium containing glucose,
but with reduced proline (SDM79S-P, -) or in the absence of glucose and reduced proline (SDM79S-G+0.1P, ○), ± Tet. F, intracellular proline concentrations
after 3 days of growth in SDM79S-P or SDM79S-G+0.1P, ± Tet. A, C, and E, growth curve (n = 3, error bars denote SD) in the presence (+T, dashed lines) or
absence of tetracycline (−T, solid line). Inserts show qRT-PCR analysis of AAT7-B gene transcript levels 3 days after start of RNAi induction. Bar shows
downregulation relative to noninduced cells. AN1 was used as reference gene (mean ± SD, n = 3, dots show individual measurements). B, D, and F,
intracellular proline concentration in cells grown for 3 days with (+Tet) or without tetracycline (−Tet), (mean ± SD, n = 3, technical repeats, similar results
were obtained in an independent biological repeat, dots show individual measurements). Statistical significance was determined using paired, two-tailed t-
test (*p ≤ 0.05; **p ≤ 0.01; n.s. not significant). Media were prepared as summarized in Table 1 and Table S1 and supplemented with 10% FBS.
EDITORS’ PICK: Proline/alanine transporters in T. bruceigrown with 5.47 mM proline (Fig. 7, C and E). The proline
content in these cells was so low that it was below the
detection limit (Fig. 7F). Knock-down of the transporters led to
a growth defect starting after 4 days of RNAi induction
(Fig. 7E). This again was accompanied by an increase in10 J. Biol. Chem. (2021) 296 100566methionine levels by about 40% while under these conditions
aspartate was increased by over 100% (Fig. S10).
To investigate the role of the transporters in the bloodstream
stage, we generated an RNAi cell line in NY-SM cells. In the
bloodstream stage, the parasite generates energy through
EDITORS’ PICK: Proline/alanine transporters in T. bruceiglycolysis, and proline is only required for protein synthesis.
The standard medium for bloodstream form culture, HMI-11,
contains 347 μM proline and a further 130 μM proline
from the serum component (50). In this medium induction of
RNAi did not lead to any growth defect (Fig. 8A). mRNA was
reduced by 80% after 2 days of tetracycline induction
(Fig. 8A), but intracellular proline was only reduced by 15%,
leaving a residual proline concentration of 600 μM (Figs. 8B and
S12A). As already shown in the procyclic form, 500 μM intra-
cellular proline (in SDM79S-G medium) did not lead to any
growth defect, so the remaining 600 μM in the BSF cells is
expected to be high enough to cover demands for protein
synthesis. To reduce proline in the growth medium, we used an
alternative medium, CMM, which allows amino acid concen-
trations to be manipulated. CMM was supplemented with 10%
(v/v) heat-inactivated FBS (standard quality, Gibco) in place of
the originally suggested FBS Gold. A slight growth defect for
NY-SM cells could be ameliorated by addition of 100 μM each
of tyrosine, phenylalanine, tryptophan, leucine, methionine,
arginine, and hypoxanthine, as recommended in the original
publication (65) (CMM+S). Cells adapted to this medium
showed a reduction of intracellular proline levels to 80 μM
compared with 700 μM for cells grown in HMI-11 (Fig. 8B).
Upon knock-down of the transporters in cells grown in
CMM+S, proline levels decreased to 40 μM, but the cells did
not exhibit a growth defect (Fig. 8, A and B and Fig. S12B).
Furthermore, AAT7-B downregulation had no effect on tran-
script levels of Tb927.8.8290 (AAT10.1), Tb927.8.8300
(AAT10.2), or Tb927.8.5450 (AAT6), in either of the two media
tested, while Tb927.11.15960 (AAT17.2) showed a small
decrease during knock-down in CMM+S (Fig. S13).
Unfortunately, a further reduction of proline concentration
in CMM+S was not possible, as FBS is essential for prolonged
growth. Therefore, the role of the transporters at very low
proline concentrations, for example, 3 μM, the concentration
of proline in the cerebrospinal fluid, could not be tested.Figure 8. RNA interference against AAT7-B in BSF T. brucei. A, growth curve
tetracycline (−T, solid line) (mean ± SD, n = 3). Insert shows qRT-PCR analysis of
RNAi induction. Bars show downregulation in cells grown in the respective med
SD, n = 3, dots show individual measurements). B, intracellular proline concentra
without tetracycline (dark gray column) (mean±SD, n = 3, dots show individual
(*p ≤ 0.05; **p ≤ 0.01; n.s. not significant).Furthermore, we cannot exclude that the remaining protein
left due to incomplete knock-down by RNAi is sufficient to
provide for the cells’ demand for proline. Therefore, we
decided to generate a knockout cell line for the AAT7-B
proline transporters. Because of the sequence homology and
substrate similarity between the AAT7-B genes, we decided to
knock out the entire locus containing the tandem repeat of the
transporter genes. The first attempt to knock out the trans-
porters by an allele replacement approach using antibiotic
cassettes supported by CRISPR-Cas9-induced double-stand
breaks at the beginning and end of the locus (66) did not
result in any viable cells after transfection, nor in cells with
incomplete knockout due to an alternative allele replacement.
The second approach used an inducible expression of sgRNA,
which should cut in the ORF of the transporter genes and
introduce a loss-of-function mutation due to microhomology-
mediated joining (67). This also failed, because all viable cell
lines that we tested avoided the knockout by introducing a
silent mutation at the sgRNA recognition site, thereby pre-
venting the generation of double-strand breaks.
Discussion
Sensing and adaptation to new environments and nutrients
are driving forces for evolution and key aspects of survival for
every organism including parasites. This seems particularly
important for T. brucei considering the massive and rapid
changes encountered when changing host. By using tran-
scriptome analyses, we monitored the response of T. brucei to
amino acid and glucose starvation and found that several
amino acid transporters were highly upregulated, among
them all genes of the amino acid transporter AAT7-B
subgroup. Functional characterization of Tb927.8.7610
(Tb427_080081900), Tb927.8.7630 (Tb427_080082000), and
Tb927.8.7640 (Tb427_080082100) showed that AAT7-B
members represent plasma membrane-localized, high- andof RNAi cells in HMI-11(-) or CMM+S (○), with (+T, dashed line) or without
AAT7-B RNAi in HMI-11 and CMM+S, RNA was extracted 2 days after start of
ium relative to noninduced cells. TERT was used as reference gene (mean ±
tions after 2 days of growth in HMI-11 or CMM+S, with (light gray column) or
points). Statistical significance was determined using paired, two-tailed t-test
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under low proline availability.
Previous studies showed that shifting procyclic form
T. brucei from glucose-rich to glucose-free medium leads to a
upregulation of proline catabolism and a concomitant increase
in proline uptake (14). Consistent with these findings, higher
expression of Tb927.8.7610, Tb927.8.7630, Tb927.8.7640 as
well as of genes involved in proline catabolism was shown in
PCF T. brucei depleted of glucose. This suggests that AAT7-B
expression is connected to a switch in energy metabolism.
While AAT7-B genes are expressed in all developmental
stages, transcript levels of the individual genes were found to
differ between BSF and PCF in several studies; these consis-
tently showed a prevalence of Tb927.8.7610 in BSF and
Tb927.8.7640 in the procyclic form (17, 39, 41–46, 68). This is
comparable to our results with approx. sixfold higher tran-
script levels of Tb927.8.7610 in BSF versus PCF and 1.5-fold
more Tb927.8.7640 in BSF versus PCF cells under standard
in vitro growth conditions.
It was found that short stumpy BSF preadapts to life in their
future insect host (69), for example, by increasing expression
of enzymes of the TCA cycle, change of their excreted end
products from pyruvate toward acetate and succinate (39,
69–71), and by elevating transcripts of proline-metabolizing
enzymes (17, 39, 41). Though higher AAT7-B transcript or
protein levels were occasionally identified in short stumpy BSF
(17, 72), in the majority of studies no major regulation was
reported (41, 45, 46, 68) indicating that AAT7-B expression
may be altered only once stumpy forms enter the insect host
i.e., during the transition to procyclic forms and induced by
nutrient or energy availability.
The transition of bloodstream to procyclic forms in vitro can
be induced by different stimuli such as a drop in temperature,
addition of citrate/cis-aconitate, mild acid, or proteases (25,
73–76). Depleting BSF of glucose also induced this transition as
well as upregulation of enzymes involved in proline metabolism
(17). Consistent with this, inhibition of the glycolytic flux by
addition of 2-deoxy-glucose to BSF cells leads to the upregu-
lation of proline dehydrogenase and also of citrate synthase (77).
Moreover, addition of phloretin, an inhibitor, or glucose
transporters causes at least partial differentiation of BSF to PCF
(77). Glucose deprivation seems to be a rather slow adaptation
and differentiation signal (76); nevertheless, it may be sufficient
to induce AAT7-B expression.
A recent study investigated that the effect of suramin
treatment on BSF showed that suramin decreases cytosolic
ATP levels and causes a concomitant increase in proline
metabolism and partial citric acid cycle activation (78).
Together with enzymes of proline metabolism and oxidative
phosphorylation, the AAT7-B transporters where identified
among the top ten proteins upregulated after prolonged sur-
amin treatment (78). This represents a scenario where glucose
is present, which theoretically should suppress proline meta-
bolism (14), but cytosolic ATP is decreased, arguing for energy
rather than glucose-dependent regulation of AAT7-B. How-
ever, suramin has diverse effects, which make it difficult to
interpret these results conclusively.12 J. Biol. Chem. (2021) 296 100566Upregulation of AAT7-B and Tb927.11.15960 mRNA was
also detected under selective proline starvation. The function
of Tb927.11.15960, which was among the most highly upre-
gulated transporters, and the proline-starvation response
need to be explored in future studies. At what point cells
sense proline starvation is unclear, given that as little as
530 μM, which is 10% proline present in standard medium, is
sufficient to sustain growth at a normal rate. Proline avail-
ability in the fly is rather controversial; reported hemolymph
concentrations range from 1 to 150 mM (11, 12, 79). More-
over, during hunger cycles or flight, proline levels can be 4–5
times lower than in resting flies (11, 26, 80). It is also poorly
understood to what extent proline is accessible to parasites in
the various organs and compartments of the fly. A single
study investigated that proline concentrations in the midgut
and hemolymph of tsetse flies suggest that hemolymph re-
flects the amino acid concentrations available to T. brucei at
least in the gut (12).
Increased expression of Tb927.8.7610 and Tb927.8.7640 can
be observed in vivo. Both transcripts are higher in the pro-
ventriculus than in the fly midgut, and they are further upre-
gulated in the salivary glands (81). Proline concentrations in
saliva might be very low as first studies failed to detect proline
or only found minute amounts (82, 83). This would call for the
expression of a high-affinity proline transporter in T. brucei
inhabiting the salivary gland. It has, however, also been shown
that T. brucei can influence the composition of tsetse fly saliva
and change the flies’ feeding behavior (84), therefore the
composition of saliva from infected flies may differ from
noninfected flies. The high-affinity transporter Tb927.8.7610
was found at significantly higher levels in salivary glands than
the low-affinity AAT7-B transporters (81). This might help
with the uptake of trace amounts of proline and might also
prepare cells for their transfer to the mammalian host. How-
ever, once salivary gland epimastigotes undergo metacyclo-
genesis, AAT7-B transporter expression is reduced again (85).
Proline uptake by the AAT7-B transporters measured in
S. cerevisiae revealed that 7610 is a high-affinity proline
transporter (Km of 17.5 μM), while 7620, 7630, and 7640 are
of low affinity (Km 600–1000 μM). Consistent with this,
Tb927.8.7610 is more highly expressed in the BSF stage, where
proline levels are rather low, around 190 μM in the blood and
2 μM in the cerebrospinal fluid (30). Tb927.8.7640 is expressed
1.5× more in procyclic forms compared with bloodstream
forms, matching increased proline levels, of 1 mM or higher in
the fly (11, 12), but as mentioned before, proline levels in the
fly are expected to differ in different organs.
In contrast to 7620, 7630, and 7640, which support growth
on proline or cysteine, 7610 only complemented growth on
cysteine. Despite these findings, subsequent short-term
transport assays characterized 7610 as a high-affinity proline
transporter, which recognized cysteine less efficiently. Selec-
tion during growth assays differs slightly, i.e., low amounts of
cysteine are required to complement the auxotrophy of
S. cerevisiae strain Y01543, while proline was used as sole ni-
trogen source for S. cerevisiae mutant 22574d, necessitating
elevated uptake to support growth. Although 7610 and 7640
EDITORS’ PICK: Proline/alanine transporters in T. bruceidiffer in affinity, the apparent Vmax values inferred from initial
transport rates are in a similar range and thus, at first sight,
cannot explain the difference in growth complementation.
However, as a considerable time-dependent decline of proline
uptake was observed for 7610, but not for the other trans-
porters, (maximal) transport rates for 7610 may drop consid-
erably in long-term experiments. Thus 7610 may only
accommodate low levels of amino acid uptake in S. cerevisiae
explaining the failure to complement growth on proline. A
decline of transport rates over time has been observed for
other transporters and may originate, for example, from a
decrease of the inwardly directed H+ electrochemical gradient,
or from inactivation e.g., by internalization (86, 87). Whether
this is also the case for 7610, when expressed in S. cerevisiae or
in T. brucei, needs to be further explored.
Proline transport studies using T. brucei Lister 427 PCF
identified a single proline transport system that shows inhi-
bition by proline, alanine, and cysteine and an apparent affinity
of 18.7 ± 1.7 μM (14, 88), but the proline concentrations used
were too low to detect a possible low-affinity uptake system.
The affinity is comparable with the Km determined for 7610
expressed in S. cerevisiae and the main substrates were also
identical. Kinetic analysis of proline uptake identified two
systems in T. cruzi (34, 89) and three in Leishmania (23, 90).
Only genes encoding the low-affinity components have been
isolated from these parasites so far, i.e., TcAAP24/
TcAAAP069 and LdAAP24, respectively (23, 34). While
physiological studies of the high-affinity system of T. cruzi
showed transport of a number of amino acids, the low-affinity
proline transport system was mainly inhibited by proline,
cysteine, valine, and alanine (89), resembling the substrate
selectivity of the TbAAT7-B transporters. TcAAP24/
TcAAAP069 expressed in baker’s yeast showed low affinity,
but a strong preference for proline, with valine and alanine as
potential substrates (34). LdAAP24 was characterized as low-
affinity transport system that preferentially recognizes pro-
line and to a lesser extent alanine (23). Additionally a shorter
isoform, generated by alternative splicing, is selective for
proline (91). In T. brucei the transporter most closely related
to TcAAP24/TcAAAP069 and LdAAP24 is the proline and
eflornithine transporter AAT6, which, when expressed in
heterologous systems, also supports transport of many other
neutral amino acids in addition to proline (32). Thus, although
having only low affinity, the substrate selectivity of TcAAP24/
TcAAAP069 and LdAAP24 is more similar to AAT7-B
members than to their syntenic gene in T. brucei. As re-
ported for LdAAP24, alanine is also a substrate for AAT7-B
when expressed in yeast. Alanine makes up a big portion of
the free amino acid pool in trypanosomes (21, 92–94) and was
shown to be involved in osmoregulation in L. donovani and
T. cruzi (23, 24), though this has not been reported yet in
T. brucei. Nevertheless, alanine is present in large quantities in
the cytosol of T. brucei (21, 92, 94) and represents an end
product of proline metabolism in PCF (16, 95). Alanine cannot
be further metabolized to CO2 as in T. cruzi (96), and therefore
needs to be exported in PCF T. brucei. While in T. brucei BSF
the major end product of glycolysis is pyruvate (65, 94, 95),alanine is also excreted in moderate amounts (65, 94), and
elevated alanine levels have been found in the serum of
infected rats (97) or voles (98), which suggests that alanine is
being exported from the parasite. Therefore, under isotonic
conditions, alanine export rather than import is expected.
However, as intracellular alanine showed only minor changes
in the AAT7-B knock-down lines, it seems rather unlikely that
AAT7-B members mediate alanine export.
Multiple transporters can help to fine-tune proline uptake
according to the current requirements, and transporters may
differ in activity depending on the environment of the parasite.
It was therefore not surprising to find more than one proline
transport system in T. brucei. Because trypanosomatids rely on
proline catabolism in their insect hosts, it seemed likely that
not only proline catabolism genes, but also proline trans-
porters would be conserved/syntenic over species (8). It was
therefore interesting to find transporters belonging to a very
different gene locus in T. brucei, compared with Leishmania or
T. cruzi, to be involved in the uptake of proline. Multiple
uptake systems can also form redundant backup systems, but
at least in our RNAi experiment under low proline conditions,
AAT6 could not sustain cell growth. This might be due to the
low affinity of AAT6 for proline and/or its broad substrate
specificity (32). RNAi knock-down in PCF also did not lead to
a growth defect under low glucose conditions. Only a com-
bination of AAT7-B knock-down together with low proline
concentration resulted in a growth defect, so AAT6 transport
activity might compensate at high proline concentrations,
though AAT6 expression was not elevated in the RNAi lines.
We also checked for transcript levels of transporters that were
regulated during short-term glucose or amino acid starvation,
but found none of them affected by knock-down of the AAT7-
B transporters. This also fits the observation that none of these
transporters, except Tb927.11.15960, showed any response to
selective proline starvation, which we expect to be the main
effect of the knock-down of AAT7-B transporters in T. brucei.
Tb927.11.15960 transcript levels were increased during proline
starvation, but under the conditions tested, the reduction of
intracellular proline in the AAT7-B RNAi lines was probably
too low to increase Tb927.11.15960 transcript levels. Based on
these data, compensation of proline uptake by these trans-
porters during AAT7-B-RNAi is not supported, but of course
we cannot exclude upregulation of other transporters that did
not show up in our initial RNAseq experiment or regulation at
the translational or posttranslational level. Although we
cannot rule out the possibility that there are additional proline
transporters besides AAT7-B and AAT6, the response of
AAT7-B members during starvation, in parallel with genes
encoding enzymes of proline catabolism, strongly indicates
that the transporters of the AAT7-B family are indeed the
main proline transporters in PCF.Experimental procedures
Plasmid constructs
For heterologous expression in S. cerevisiae, open reading
frames (ORFs) of the genes Tb927.8.7610 (Tb427_080081900),J. Biol. Chem. (2021) 296 100566 13
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(Tb427_080082100) were PCR amplified from genomic DNA of
T. b. brucei Lister 427 using PfuUltra DNA polymerase AD
(Stratagene) and primers 50-CGGAATTCATGACCAGCAT-
CAATGCCCAACC-30 and 50-CGCGGATCCTCATCCCA-
CAGTAACTGCCCAAATGG-30, and cloned into the yeast
expression vector pDR197 (99) using the EcoRI and BamHI re-
striction sites, resulting in construct 7610 (for Tb927.8.7610),
7630 (for Tb927.8.7630), 7640 and 76400 (for Tb927.8.7640). The
construct 7630 was mutated by two rounds of site-directed
mutagenesis PCR using first primers 50-CCTATCTTTTTCA-
GATTACCGCGTATG-30 and 50-CATACGCGGTAATCT
GAAAAAGATAGG-30, to give construct 76300, and in a second
step primers 50-CGTTCTGGTTGTCACCATTGCGATGGG-
30 and 50-CCCATCGCAATGGTGACAACCAGAACG-30 to
obtain construct 7620, coding for an identical amino acid
sequence as for Tb427.08.7620 described in TriTrypDB.
The construct required for the simultaneous knock-down of
all genes of the AAT7-B locus was generated by amplifying a
390 bp DNA fragment spanning the 30end of the ORF and the
beginning of the 30UTR using genomic DNA of T. b. brucei
Lister 427 and primers 50-CCGGAAGCTTGGATCCA
AAGGTTGGTCCCTTTTATTACATTTCC-30 and 50-TG
GCTCTAGACTCGAGCGACACGAACAAAGGAAATAATT
GAC-30. The fragment was cloned into the stem-loop vector
pALC14 (a derivative from pLew100 (20, 48, 100), containing a
puromycin resistance), in two steps, inserting the first fragment
using the XhoI and BamHI and the second into HindIII and
XbaI.
For inducible overexpression of tagged versions of
Tb927.8.7610 and Tb927.8.7640, the ORFs of construct 7610
and 7640 were cloned in the plasmid pJM-2 (based on
pLew100 (48) containing a puromycin resistance and a 3x
cMyc cassette for N-terminal tagging (101)), creating the
plasmids cMyc-7610 and cMyc-7640, respectively.
S. cerevisiae strains, growth conditions, and transport assays
S. cerevisiae was transformed according to Dohmen et al.
(102). To test growth on different amino acids, ORFs were
expressed in the following S. cerevisiae mutants: 21.983c
(Matα, gap1-1, can1-1, ura3) (103) for arginine, 22574days
(Matα, ura3-1, gap1-1, put4-1, uga4-1) (104) for citrulline, γ-
aminobutyric acid and proline, 22Δ6AAL (Matα, ura 3–1,
gap1-1, put4-1, uga4-1, lyp1/alp1::hisG, can1::hisG, hip1:hisG)
(105) to test for lysine, 30.537a (Matα, gap1-1, dip5::kanMX2,
ura3; kind gift of Professor Bruno André, Université Libre de
Bruxelles) for glutamate and aspartate, JT16 (Matα, hip1-614,
his4-401, can1, ino1, ura3-52) (106) for histidine, Y01543
(Matα, his3Δ1, leu2Δ0, met15Δ0, ura3Δ0, YLL055w::kanMX4;
Euroscarf) for cysteine, and YDR544 (Matα, ura3-1, gap1-1,
put4-1, uga4-1, ssy1::kanMX) (107) for the amino acids
methionine, valine, isoleucine, leucine, threonine, tryptophan,
and tyrosine. Nonselective and selective conditions were: for
mutant 21.983c, synthetic minimal glucose medium (MM,
1.7 g L−1 yeast nitrogen base without amino acids and without
ammonium sulfate (Difco), and 20 g L−1 glucose) containing
5 g L−1 (NH4)2SO4, or in minimum buffered (pH 6.1) medium14 J. Biol. Chem. (2021) 296 100566(M.am, without ammonium sulfate, (108)) containing 1 g L−1
arginine instead of (NH4)2SO4; for mutant 22574d, MM con-
taining 5 g L−1 (NH4)2SO4, or M.am medium containing either
1 g L−1 proline, 1 g L−1 γ-amino butyric acid, or 1 g L−1
citrulline; for mutant 22Δ6AAL, MM containing 1 g L−1 urea
and 1 g L−1 lysine or 100 μM lysine; for mutant 30.537a, MM
containing 5 g L−1 (NH4)2SO4, or M.am medium containing
either 1 g L−1 glutamate, or 0.5 g L−1 aspartate; for mutant
JT16, synthetic complete (SC, without histidine (109)) medium
containing either 20 mM or 5 or 6 mM histidine; for mutant
Y01543, MM containing 50 mg L−1 leucine, 50 mg L−1 histi-
dine and 50 mg L−1 methionine, or M.am containing 10 mM
(NH4)2SO4, 50 mg L
−1 leucine, 50 mg L−1 histidine and
100 μM cysteine; and for mutant YDR544, MM containing
5 g L−1 (NH4)2SO4, or MM containing either 1 mM isoleucine,
5 mM leucine, 1 mM methionine, 5 mM threonine, 1 mM
tryptophan, 1 mM tyrosine, or 1 mM valine. As positive
controls for S. cerevisiae growth on aspartate, glutamate, and
lysine, we used a construct for the expression of the amino acid
transporter AAP6, of Arabidopsis thaliana (AtAAP6, (105)),
for arginine the arginine transporter, AAP3, of L. donovani
(LdAAP3, (107)), for γ-amino butyric acid the high-affinity
GABA transporter, GAT1, of A. thaliana (AtGAT1, (110)),
for cysteine the high-affinity cysteine transporter from
S. cerevisiae (ScYct1, (111)), and for all other amino acids the
general amino acid permease AAP2 of A. thaliana (AtAAP2,
(112)).
Transport assays were performed as described before (113)
with slight modifications. Transformed S. cerevisiae mutant
22574d was grown in MM containing 5 g L−1 ammonium
sulfate to an OD578 of 0.6, Y01543 was grown in MM con-
taining 5 g L−1 ammonium sulfate, 50 mg L−1 leucine,
50 mg L−1 histidine, and 50 mg L−1 methionine. To reduce
transport by endogenous transport systems, cells were culti-
vated for 1 h in yeast extract peptone dextrose (YPD) medium,
before cells were harvested by centrifugation. Cells were
washed once with water, diluted to an OD578 of 0.6, pelleted
and resuspended in 1/10 volume of buffer A (0.6 M sorbitol,
50 mM potassium phosphate, pH 7.0), and placed on ice. For
determination of pH dependence of proline uptake, buffer A
was adjusted to pH 4.5, 5.0, 5.5, 6.0, 6.5, 7.0, or 7.5. Prior to
starting the transport assay, cells were incubated for 5 min at
30 C in the presence of 100 mM glucose. To start the assay an
equal volume of cell suspension and substrate were mixed and
incubated at 30 C. Substrate mixtures contained varying
concentrations of nonlabeled proline spiked with L-
[2,3,4,5-3H]-proline (MT-522, Hartmann Analytics, specific
activity 2.1 TBq mmol−1) to a final activity of 55.5 kBq ml−1
and competitor compounds as specified. For measurement of
alanine uptake, nonlabeled alanine was spiked with L-[2,3-3H]-
alanine (MT-866, Hartmann Analytics, specific activity 1.41
TBq mmol−1) to a final activity of 55.5 kBq ml−1. For cysteine
transport, nonlabeled cysteine was spiked with L-[35S]-cysteine
(ARS0101, Hartmann Analytics, specific activity 39.8 TBq
mmol−1) to a final activity of 107 kBq ml−1 and 250 μM DTT
was added. After 15, 30, 45, 60, and 75 s (for 7610, unless
stated otherwise) or 30, 60, 120, 180, and 300 s (for 7620, 7630,
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filtered on glass microfiber filter (Whatman grade GF/C), and
washed twice with 4 ml chilled buffer A. The filters were
immersed in 4 ml Ultima Gold XR (PerkinElmer) scintillation
cocktail and samples were analyzed by liquid scintillation
counting on a Tri-Carb 2910 TR (PerkinElmer). Results are
displayed as uptake rates calculated from the time series per-
formed in each transport assay. As background, transport rates
measured in cells transformed with the yeast expression vector
were subtracted from the sample values. Calculation of kinetic
parameter of the transporters was performed using nonlinear
least squares regression using the Michaelis–Menten kinetic
model.
T. b. brucei cell culture
Procyclic T. brucei 29-13 cells (48), SmOxP9-Cas9 cells (66),
and thereof derived cells were routinely cultured at 27 C in
standard medium SDM79 (49) (purchased from BioConcept,
Switzerland) or in a home-made medium SDM79S (containing
low glucose, low proline, and/or low amino acid concentra-
tions, see Table 1, for detailed composition Table S1) i.e., for
starvation experiments.
All media were supplemented with 7.5 mg L−1 hemin and
15 mg L−1 folic acid (as hemin-folate solution). For continuous
cultivation and growth curves, media were further supple-
mented with 10% (v/v) heat-inactivated fetal bovine serum
(FBS) (Gibco). Depending on cell line, PCF cells were grown
with 50 μg ml−1 hygromycin, 15 μg ml−1 neomycin, 2.5 μg ml−1
phleomycin, 10 μg ml−1 blasticidin, and/or 1 μg ml−1 puro-
mycin, as required.
Bloodstream form T. brucei NY-SM (48), SmOxB4-Cas9
cells (66), and derived cell lines were cultured at 37 C under
5% CO2 in medium HMI-11 (50), in home-made medium
HMIS (containing low amino acids or low glucose, see Table 1,
for detailed composition Table S1), or in Creek’s minimum
medium (CMM), supplemented with tyrosine, phenylalanine,
tryptophan, leucine, methionine, arginine, and hypoxanthine,
each at 100 μM (CMM+S) (65). For continuous growth HMI-
11 and CMM were prepared with 10% (v/v) heat-inactivated
FBS (Gibco) as serum component. BSF cells were grown in
the presence of 5 μg ml−1 hygromycin, 1.25 μg ml−1 phleo-
mycin, 5 μg ml−1 blasticidin, and/or 0.1 μg ml−1 puromycin, as
required.
Cells were subcultured every 24 h to keep them at cell
densities of 0.1–1.5 × 107 cell ml−1 for procyclic T. brucei
cultures and 0.1–2 × 106 cells ml−1 for BSF trypanosomes. For
growth curves cells were grown in a volume of 1 ml in 24-well
plates, diluted every day to the same starting concentration,
and for induction of RNAi tetracycline was added at a con-
centration of 1 μg ml−1.
For adaption of cells to new media (e.g., low glucose, or low
proline medium for PCF or CMM for BSF), cells were diluted
from a standard log-phase culture in standard medium
(commercial SDM79 or standard HMI-11) with new medium
and grown for 3–4 days with daily dilutions with fresh media
conditions, so cells could multiply at least 100-fold, allowing a1:100 dilution of the old media and adaption of a stable
growth, before start of any experiment. For adaption of PCF to
low glucose–low proline medium (SDM79S-G+0.1P), cells
were first adapted to low glucose medium (SDM79S-G) and
then adapted to SDM79S-G+0.1P.
Transfection of trypanosomes
Plasmid DNA for generation of RNAi cell lines or for
expression of tagged proteins was linearized by NotI and pu-
rified using the NucleoSpin Gel and PCR Clean-up kit
(Macherey-Nagel). For transfection 1 × 107 cells of a BSF NY-
SM or PCF 29-13 mid-log culture were harvested by centri-
fugation at 800g. After complete removal of the supernatant,
the cell pellet was resuspended in 100 μl Tb-BSF buffer
(90 mM Na2HPO4, 5 mM KCl, 0.15 mM CaCl2, 50 mM
HEPES, pH 7.3, (36)) containing 10 μg of linearized plasmid
DNA, and electroporated using a Lonza 4D-Necleofector
System (Primary Cell P3, pulse code FI-115). Pulsed cells were
transferred to 10 ml fresh medium for 12–16 h. After recovery
cells were further diluted 1:5 and 1:25 and PCF cells were
spread onto a 48 well plate (0.4-2 × 105 cells well−1), while BSF
cells were spread on 96 well plates (0.4–2 × 104 cells well−1).
For selection and generation of clonal populations, standard
medium was supplemented with 20% FBS and selective anti-
biotics were added at the following concentrations, for PCF,
50 μg ml−1 hygromycin, 30 μg ml−1 neomycin, 5 μg ml−1
phleomycin, and/or 2 μg ml−1 puromycin; for BSF, 5 μg ml−1
hygromycin, 5 μg ml−1 neomycin, 2.5 μg ml−1 phleomycin,
and/or 0.2 μg ml−1 puromycin, as required.
CRISPR-Cas9 knockout generation in T. brucei
For generation of AAT7-B knockout cell lines by allelic
replacement with the help of CRISPR-Cas9, sgRNA flanking
the AAT7-B locus was designed with the help of EuPaGDT
web tool (114), and PCR and T. brucei transfection were
performed following the published protocol (66). The guide
RNA template containing a T7 promoter for in vivo tran-
scription was generated by PCR using for the 50-sgRNA the
primer 50-GAAATTAATACGACTCACTATAGGAGCTGG
GCAAGCGAATGCTG-30 50-GTTTTAGAGCTAGAAATA
GC-30 and for the 30-sgRNA the primer 50-GAAATTAA-
TACGACTCACTATAGGTGGAGCGAACGAATGAGAGA
GTTTTAGAGCTAGAAATAGC-30, together with the guide
RNA scaffold primer 50-AAAAGCACCGACTCGGTGCCA
CTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAAC
TTGCTATTTCTAGCTCTAAAAC-30. Resistance markers
for replacement of both alleles were amplified for hygromycin
resistance from the plasmid pPOTv7-HYG-mNG and for





CTACCAGAACC-30. All PCR reactions were pooled and
cleaned using the NucleoSpin Gel and PCR Clean-up kit
(Macherey-Nagel), and cleaned DNA was used for theJ. Biol. Chem. (2021) 296 100566 15
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cells. Transfection and selection of cells were performed as
described above. Viable clones were tested by PCR for inte-
gration of both resistance markers and for the loss of all
AAT7-B genes.
For generation of inducible CRISPR-Cas9 knockout cell
lines (67), a guide RNA was designed, which induced a
double-strand break the ORF of all genes of the AAT7-B
locus. For this the oligos 50-AGGGACCACTGCTGTTGG
CGGCTGC-30 and 50-AAACGCAGCCGCCAACAGCAGT
GGT-30 were annealed to each other and cloned into the
plasmid pT7sgRNA (67). The plasmid was linearized with NotI
and used for transfection of PCF SmOxP9-Cas9 and BSF
SmOxB4-Cas9 cells, with the transfection protocol as
described above. Following selection, sgRNA expression was
induced by addition of 1 μg ml−1tetracycline to the media for
7 days. After the induction period, the ORFs of the AAT7
genes were amplified by PCR and sequenced to confirm
microhomology repair events of the CRISPR-Cas9-induced
double-strand breaks.
Starvation experiments and RNA extraction
For starvation experiments, mid-log cultures of PCF 29-
13 cells were grown in SDM79 with 10% FBS. 5 × 107 cells
were harvested by centrifugation at 800g for 10 min at room
temperature, followed by one wash with an SDM79S base
(SDM79S without amino acids or glucose), containing no
amino acids, no glucose (detailed composition in Table S1).
Cell pellets were resuspended in 10 ml fresh starvation me-
dium prewarmed to 27 C. Media used were either commercial
SDM79 containing 10% (v/v) FBS (named SDM79+FBS, or
FBS for the starvation experiment) or the starvation medium
SDM79S containing glucose and all standard amino acids (Ala,
Arg, Asn, Asp, Cystine, Glu, Gln, Gly, His, Ile, Leu, Lys, Met,
Orn, Phe, Pro, Ser, Taurine, Thr, Trp, Tyr, Val) (SDM79S+AA,
or +AA), SDM79S containing glucose but no amino acids
(SDM79S-AA, or -AA), SDM79S containing no glucose, but all
amino acids and 50 mM N-acetyl glucosamine (SDM79S-G, or
-G). For investigation of the selective effect of proline during
starvation, further media were prepared, SDM79S containing
glucose and all amino acids with the exception of proline
(SDM79S-P, or -P) and SDM79S containing glucose and
5.3 mM proline, but no other amino acids (SDM79S-AA+P, or
-AA+P). None of the media used for the starvation experi-
ments, except SDM79+FBS, was prepared with FBS. For a
summary of media compositions, see Table 1, and for detailed
composition, see Table S1.
For starvation experiments using BSF NY-SM cells, cells
were grown to mid-log phase in HMI-11, and 5 × 107 cells
were harvested by centrifugation at 800g for 10 min at room
temperature, followed by one wash with HMIS salt base,
containing glucose, but no amino acids, and no vitamins
(detailed composition in Table S1). Cell pellets were resus-
pended in 50 ml fresh, prewarmed starvation medium and
incubated at 37 C with 5% CO2. Media for BSF starvation
were HMI-11 containing 10% (v/v) FBS (HMI-11, or FBS), the16 J. Biol. Chem. (2021) 296 100566starvation medium HMIS containing glucose and amino acids
(HMIS+AA, or +AA), HMIS containing glucose, but no amino
acids (HMIS-AA, or -AA), and HMIS containing amino acids
but no glucose (HMIS-G, or -G). None of the starvation media,
except HMI-11, was prepared containing FBS. The overview of
all media used is summarized in Table 1 and detailed media
compositions are summarized in Table S1.
For the starvation period cells were kept in 15 ml (PCF) or
50ml (BSF) Falcon tubes with open lids, and cells weremixed by
inversion every 30 min. Cells were starved for 2 h, 4 h, or 6 h,
followed by RNA extraction using guanidium thiocyanate (116).
In short, cells were harvested by centrifugation andwashed once
with phosphate buffered saline (PBS) followed by lysis of the
cells with solution D (4 M guanidine thiocyanate, 25 mM so-
dium citrate pH 7.0, 0.5% (v/v) sodium lauroyl sarcosinate,
0.1 M 2-mercaptoethanol). The cell lysate was extracted with
acidic phenol-chloroform-isoamyl alcohol, 150:49:1, (v/v/v)
(using ROTIAqua-Phenol for RNA extraction, Carl Roth, CH)
and RNA from the aqueous phase was precipitated with ethanol.
The RNA was treated with DNase I followed by an additional
acidic phenol extraction and ethanol precipitation.
For assessment of RNAi efficiency of RNAi cell lines, cells
were grown in medium with or without 1 μg ml−1 tetracycline
for 2 days (BSF), or 3 days (PCF), and RNA was extracted with
the SV Total RNA Isolation System (Promega).
RNAseq and data analysis
RNA extracted from the starvation experiment using gua-
nidine thiocyanate (116) was sent to Fasteris SA (Geneva,
Switzerland) for RNAseq analysis. Raw RNA was poly-A pu-
rified and cDNA libraries were prepared using the Ilumina
TruSeq stranded mRNA kit. Sequencing was performed using
Ilumina NextSeq with single-reads at 150 bp size, or Illumina
HighSeq with paired reads at 150 bp size. Sequencing depth
averaged >20 million reads per sample.
Reads were mapped to all transcripts of T. b. brucei Lister
427 (51) (TriTrypDB release 46; referred to as Lister
427_2018), using the integrated bowtie tool (117) on a galaxy
web server (usegalaxy.org, (118)) with default settings, allowing
two mismatches within 28 bp of the seed. Read counts mapped
per ORF were divided by the total number of mapped reads
per sample to obtain the RPM values (reads per million
mapped reads) for all identified genes. For each cell stage
individually, genes were removed from the dataset, which had
fewer than 100 mapped reads within the coding region of the
gene, over all samples. For further refinement, all pseudogenes
were removed. A separate table was generated containing all
amino acid transporters including pseudogenic transcripts
(included in Table S2). For all remaining identified T. b. brucei
Lister 427_2018 genes, orthologous genes within the T. b.
brucei TREU 927 genome were matched over identical
OrthoMCL groups (119), which were extracted from Tri-
TrypDB. Orthologues groups with multiple members that
could not be uniquely matched were either noted as such and
all matching 927 Gene IDs listed, or they were manually
matched according to their genomic location. For assessment
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amino acids or glucose were compared with RPM values of
cells grown with glucose and with amino acids.
Quantitative RT-PCR
RNA extracted from the starvation experiments or fromRNAi
cell lines was transcribed to cDNAusing PrimeScript RT reagent
kit (Takara Bio) using both oligo dT and random sixmer primers.
Quantitative PCR was performed using SYBR Premix Ex
Taq II (Tli RNase H Plus) (Takara Bio) on a LightCycler 96 Real-
Time PCR System (Roche). Primers for the simultaneous
detection of the genes Tb927.8.7610 (Tb427_080081900),
Tb927.8.7630 (Tb427_080082000), and Tb927.8.7640
(Tb427_080082100) were 7610F 50-TGGACATGACAAACCG
TTCG-30 and 7610R 50-TGGGAAGACACATACCCATCG-30,
primers for Tb927.11.15960 (Tb427_110178500) were 15960F
50-GGCACTTTTTACGGCTTTGTTGC-30 and 15960R
50-CACACCTATAGAGCCTATCAGC-30 and for Tb927.8.
8300 (Tb427_080088500) were 8300F 50-TGATGGTTG-
CAATGGTTGGC-30 and 8300R 50-TGAATTGCGAAGTGC-
CATGG-30. Further genes analyzed were Tb927.8.8290
(TbAAT10.1, Tb427_080088400) (33), and Tb927.8.4710,
Tb927.8.4720, Tb927.8.4730, Tb927.8.4740, Tb927.8.4750
(TbAAT5-2/3/4/5/6, Tb427_080052200, Tb427_080052300,
Tb427_080052400, Tb427_080052500, Tb427_080052600) us-
ing primers published previously (31). Further primers were
designed to detect the amino acid transporter Tb927.8.5450
(AAT6, Tb427_080059900), 5450F 50-TGCGGTGTTTTTG
CTTCCAG-30 and 5450R 50-TTCGTTCCAAGCAGCAACTG-
30. For normalization published primers for the reference genes
telomerase reverse transcriptase (TERT, Tb927.11.10190,
Tb427_110110500) (120) or the putative AN1-like zinc finger
protein (AN1, Tb927.10.12970, Tb427_100136900) (121) were
used. qRT-PCR reactionswere conducted on three RNA samples
from independent experiments per condition with at least two
technical replicas. Statistical significance was determined using
paired, two-tailed t-tests.
Amino acid extraction and analysis
For analyses of intracellular metabolites from RNAi cell
lines, cells were cultivated in the presence or absence of
tetracycline for 2 days (BSF) or 3 days (PCF), and metabolites
were extracted by organic solvent extraction (122). 5 ×
107 cells of a mid-log cell cultures were rapidly cooled to 0 C
in an ethanol/dry-ice bath. Cells were washed three times with
ice-cold PBS (137 mM NaCl, 2.7 mM NaCl, 10 mM Na2HPO4,
1.76 mM KH2PO4, pH 7.2). The cell pellet was extracted with a
mixture of chloroform, methanol, and water at a ratio of 1:3:1,
by vortex shaking for 1 h at 4 C. Subsequently the suspension
was centrifuged to remove cell debris and the clear superna-
tant was collected and stored until analysis at –80 C. Free
amino acids were determined by ARC (Analytical Research
and Services, University of Bern) based on the method of
Bidlingmeyer and coworkers (123); therefore, extracts were
derivatized with phenyl isothiocyanate and analysis was per-
formed by RP-HPLC coupled to UV detection (33).To compensate for variations in cell number represented in
the final extract due to loss in the washing steps, the amount of
each amino acid was normalized to the sum of all amino acids
in the sample sufficiently separated during the analysis (Asp,
Glu, Pro-OH, Ser, Gly, Arg, Val, Met, Ile, Leu, Lys for PCF; and
Glu, Pro-OH, Asn, Ser, Gln, Gly, Arg, Tyr, Ile, Leu, Phe, Lys for
BSF) excluding alanine and proline, which are the main sub-
strates of the studied transporters. Extraction and analysis
were performed as technical triplicates, and the normalized
amino acid amounts were averaged between treatments
(grown with or without tetracycline) followed by multiplica-
tion with the average amino acid sum over all samples (with
and without tetracycline) to again obtain amino acid amounts.
Assuming no loss of amino acids during the extraction and
analysis, the obtained amino acid amounts were converted to
intracellular concentrations assuming for PCF a cell volume of
3.31 μl 108 cells−1 (64), and for BSF a cell volume of 5.89 μl
108 cells−1 (64). For calculation of relative amino acid contents,
following the previous normalization steps, the average amino
acid amounts in cells grown without tetracycline were set to
100%. As the amount of amino acids was dependent on the
growth conditions (media), some amino acids could not be
sufficiently separated by HPLC to allow reliable quantification
(i.e., Asn, Gln, Thr), these amino acids as well as amino acids
that were present at concentrations close to the detection limit
(Tyr, Phe, Trp) were omitted from some of the analysis. For
statistical analysis data were treated as paired samples and
tested using a two-tailed t-test.Immunolocalization
For immunolocalization of N-terminal cMyc tagged ORFs
of Tb927.8.7610 and Tb927.8.7640, PCF cells transfected with
the tagging construct cMyc-7610 and cMyc-7640 were grown
with 1 μg ml−1 tetracycline for 3 days to induce overexpression
of the tagged proteins. Cells were harvested by centrifugation
at 800g and washed once with PBS-G (PBS containing 10 mM
glucose). Cells were fixed in solution with fresh 4% (w/v)
paraformaldehyde in PBS, settled on Superfrost plus slides
(Thermo Scientific), and permeabilized with 0.2% (v/v) Triton
X-100 in PBS. Cells were probed with antibodies against cMyc
(polyclonal, rabbit, Bethyl Laboratories) and against EP pro-
cyclin (monoclonal, mouse, CLP001AP, Cedarlane) at a dilu-
tion of 1:1000. Following the application of the secondary anti-
mouse antibody conjugated with Alexa Fluor 488 (polyclonal,
goat, Life Technologies) and anti-rabbit antibody conjugated
with Alexa Fluor 594 (polyclonal, goat, Life Technologies),
slides were mounted to coverslips with Vectashield containing
1.5 μM DAPI (Vector Laboratories). Images were recorded on
a Leica DM RXE confocal microscope equipped with a Leica
TCS SP2 confocal scanner. Final images were created and
analyzed using Fiji (124).
Data availability
Raw RNA-seq rea data have been deposited at the European
Nucleotide Archives (ENA, http://www.ebi.ac.uk/ena) under
the study accession number PRJEB40295. Individual data filesJ. Biol. Chem. (2021) 296 100566 17
EDITORS’ PICK: Proline/alanine transporters in T. bruceiare available under the accession numbers ERS5057102–
ERS5057121.
Supporting information—This article contains supporting
information (31–33, 103, 105, 108–110).
Acknowledgments—We thank Peter Bütikofer (University of Bern)
for providing the cell lines SmOxP9-Cas9 and SmOxB4-Cas9, and
A. C. H. also thanks him for encouragement and support. We
thank Corina Wirdnam and Marianne Suter Grotemeyer
(University of Bern) for technical assistance and helpful discussions.
Author contributions—Conceptualization: D. R.; Data curation:
A. C. H., Q.-F. O.; Formal analysis: A. C. H., A. N.; Funding acqui-
sition: D. R.; Investigation: A. C. H., V. E.; Project administration:
D. R.; Supervision: D. R.; Validation: A. C. H.; Writing - original draft:
A. C. H., D. R.; Writing- review and editing: A. C. H., I. R., D. R.
Funding and additional information—This work was supported by
the Swiss National Science Foundation CRSII3_141913 and
31003A_182426 (DR) and the University of Bern.
Conflict of interest—The authors declare that they have no conflicts
of interest with the contents of this article.
Abbreviations—The abbreviations used are: BSF, bloodstream form;
PCF, procyclic culture form; TCA, tricarboxylic acid; TERT, telo-
merase reverse transcriptase.
References
1. Simpson, A. G. B., Stevens, J. R., and Lukes, J. (2006) The evolution and
diversity of kinetoplastid flagellates. Trends Parasitol. 22, 168–174
2. Jackson, A. P., Otto, T. D., Aslett, M., Armstrong, S. D., Bringaud, F.,
Schlacht, A., Hartley, C., Sanders, M., Wastling, J. M., Dacks, J. B.,
Acosta-Serrano, A., Field, M. C., Ginger, M. L., and Berriman, M. (2016)
Kinetoplastid phylogenomics reveals the evolutionary innovations
associated with the origins of parasitism. Curr. Biol. 26, 161–172
3. Chaudhary, K., and Roos, D. S. (2005) Protozoan genomics for drug
discovery. Nat. Biotechnol. 23, 1089–1091
4. Jackson, A. P. (2015) Genome evolution in trypanosomatid parasites.
Parasitology 142 Suppl, S40–56
5. Smith, T. K., Bringaud, F., Nolan, D. P., and Figueiredo, L. M. (2017)
Metabolic reprogramming during the Trypanosoma brucei life cycle.
F1000Research 6, 1–12
6. Opperdoes, F. R., and Coombs, G. H. (2007) Metabolism of Leishmania:
Proven and predicted. Trends Parasitol. 23, 149–158
7. Minning, T. A., Weatherly, D. B., Atwood, J., Orlando, R., and Tarleton,
R. L. (2009) The steady-state transcriptome of the four major life-cycle
stages of Trypanosoma cruzi. BMC Genomics 10, 370
8. Bringaud, F., Barrett, M. P., and Zilberstein, D. (2012) Multiple roles of
proline transport and metabolism in trypanosomatids. Front. Biosci.
(Landmark Ed.) 17, 349–374
9. Marchese, L., Nascimento, J. de F., Damasceno, F. S., Bringaud, F.,
Michels, P. A. M., and Silber, A. M. (2018) The uptake and metabolism
of amino acids, and their unique role in the biology of pathogenic try-
panosomatids. Pathogens 7, 36
10. Roditi, I., and Lehane, M. J. (2008) Interactions between trypanosomes
and tsetse flies. Curr. Opin. Microbiol. 11, 345–351
11. Bursell, E. (1963) Aspects of the metabolism of amino acids in the tsetse
fly, Glossina (Diptera). J. Insect Physiol. 9, 439–452
12. Balogun, R. A. (1974) Studies on the amino acids of the tsetse fly,
Glossina morsitans, maintained on in vitro and in vivo feeding systems.
Comp. Biochem. Physiol. A. Comp. Physiol. 49, 215–22218 J. Biol. Chem. (2021) 296 10056613. Mantilla, B. S., Marchese, L., Casas-Sánchez, A., Dyer, N. A., Ejeh, N.,
Biran, M., Bringaud, F., Lehane, M. J., Acosta-Serrano, A., and Silber, A.
M. (2017) Proline metabolism is essential for trypanosoma brucei brucei
survival in the tsetse vector. PLoS Pathog. 13, 1–29
14. Lamour, N., Riviere, L., Coustou, V., Coombs, G. H., Barrett, M. P., and
Bringaud, F. (2005) Proline metabolism in procyclic Trypanosoma
brucei is down-regulated in the presence of glucose. J. Biol. Chem. 280,
11902–11910
15. Spitznagel, D., Ebikeme, C., Biran, M., Nicabháird, N., Bringaud, F.,
Henehan, G. T. M., and Nolan, D. P. (2009) Alanine aminotransferase of
Trypanosoma brucei- a key role in proline metabolism in procyclic life
forms. FEBS J. 276, 7187–7199
16. Coustou, V., Biran, M., Breton, M., Guegan, F., Rivière, L., Plazolles, N.,
Nolan, D., Barrett, M. P., Franconi, J.-M., and Bringaud, F. (2008)
Glucose-induced remodeling of intermediary and energy metabolism in
procyclic Trypanosoma brucei. J. Biol. Chem. 283, 16342–16354
17. Qiu, Y., Milanes, J. E., Jones, J. A., Noorai, R. E., Shankar, V., and Morris,
J. C. (2018) Glucose signaling is important for nutrient adaptation
during differentiation of pleomorphic African trypanosomes. mSphere 3,
1–18
18. Ebikeme, C. E., Peacock, L., Coustou, V., Riviere, L., Bringaud, F.,
Gibson, W. C., and Barrett, M. P. (2008) N-acetyl D-glucosamine
stimulates growth in procyclic forms of Trypanosoma brucei by
inducing a metabolic shift. Parasitology 135, 585–594
19. Marciano, D., Maugeri, D. A., Cazzulo, J. J., and Nowicki, C. (2009)
Functional characterization of stage-specific aminotransferases from
trypanosomatids. Mol. Biochem. Parasitol. 166, 172–182
20. Bochud-Allemann, N., and Schneider, A. (2002) Mitochondrial substrate
level phosphorylation is essential for growth of procyclic Trypanosoma
brucei. J. Biol. Chem. 277, 32849–32854
21. Williamson, J., and Desowitz, R. S. (1961) The chemical composition of
trypanosomes. I. Protein, amino acid and sugar analysis. Exp. Parasitol.
11, 161–175
22. Vieira, L. L., Lafuente, E., Gamarro, F., and Cabantchik, Z. (1996) An
amino acid channel activated by hypotonically induced swelling of
Leishmania major promastigotes. Biochem. J. 319(Pt 3), 691–697
23. Inbar, E., Schlisselberg, D., Suter Grotemeyer, M., Rentsch, D., and
Zilberstein, D. (2013) A versatile proline/alanine transporter in the
unicellular pathogen Leishmania donovani regulates amino acid
homoeostasis and osmotic stress responses. Biochem. J. 449, 555–566
24. Rohloff, P., Rodrigues, C. O., and Docampo, R. (2003) Regulatory volume
decrease in Trypanosoma cruzi involves amino acid efflux and changes
in intracellular calcium. Mol. Biochem. Parasitol. 126, 219–230
25. Brun, R., and Schönenberger, M. (1981) Stimulating effect of citrate and
cis-Aconitate on the transformation of Trypanosoma brucei blood-
stream forms to procyclic forms in vitro. Z. Parasitenkd. 66, 17–24
26. Bursell, E. (1966) Aspects of the flight metabolism of tsetse flies (Glos-
sina). Comp. Biochem. Physiol. 19, 809–818
27. Capewell, P., Cren-Travaillé, C., Marchesi, F., Johnston, P., Clucas, C.,
Benson, R. A., Gorman, T.-A., Calvo-Alvarez, E., Crouzols, A., Jouvion,
G., Jamonneau, V., Weir, W., Stevenson, M. L., O’Neill, K., Cooper, A.,
et al. (2016) The skin is a significant but overlooked anatomical reservoir
for vector-borne African trypanosomes. Elife 5, 1–17
28. Tanowitz, H. B., Scherer, P. E., Mota, M. M., and Figueiredo, L. M.
(2017) Adipose tissue: A safe haven for parasites? Trends Parasitol. 33,
276–284
29. Mogk, S., Boßelmann, C. M., Mudogo, C. N., Stein, J., Wolburg, H., and
Duszenko, M. (2017) African trypanosomes and brain infection - the
unsolved question. Biol. Rev. Camb. Philos. Soc. 92, 1675–1687
30. Wishart, D. S., Knox, C., Guo, A. C., Eisner, R., Young, N., Gautam, B.,
Hau, D. D., Psychogios, N., Dong, E., Bouatra, S., Mandal, R., Sinelnikov,
I., Xia, J., Jia, L., Cruz, J. A., et al. (2009) HMDB: A knowledgebase for
the human metabolome. Nucleic Acids Res. 37, D603–D610
31. Mathieu, C., Macêdo, J. P., Hürlimann, D., Wirdnam, C., Haindrich, A.
C., Suter Grotemeyer, M., González-Salgado, A., Schmidt, R. S., Inbar,
E., Mäser, P., Bütikofer, P., Zilberstein, D., and Rentsch, D. (2017)
Arginine and lysine transporters are essential for Trypanosoma brucei.
PLoS One 12, e0168775
EDITORS’ PICK: Proline/alanine transporters in T. brucei32. Mathieu, C., González Salgado, A., Wirdnam, C., Meier, S., Grotemeyer,
M. S., Inbar, E., Mäser, P., Zilberstein, D., Sigel, E., Bütikofer, P., and
Rentsch, D. (2014) Trypanosoma brucei eflornithine transporter AAT6
is a low-affinity low-selective transporter for neutral amino acids. Bio-
chem. J. 463, 9–18
33. Macedo, J. P., Currier, R. B., Wirdnam, C., Horn, D., Alsford, S., and
Rentsch, D. (2017) Ornithine uptake and the modulation of drug
sensitivity in Trypanosoma brucei. FASEB J. 31, 4649–4660
34. Saye, M., Miranda, M. R., Girolamo, F. Di, De Los Milagros Cámara, M.,
and Pereira, C. A. (2014) Proline modulates the trypanosoma cruzi
resistance to reactive oxygen species and drugs through a novel D, L-
Proline transporter. PLoS One 9, e92028
35. Vincent, I. M., Creek, D., Watson, D. G., Kamleh, M. A., Woods, D. J.,
Wong, P. E., Burchmore, R. J. S., and Barrett, M. P. (2010) A molecular
mechanism for eflornithine resistance in African trypanosomes. PLoS
Pathog. 6, 1–9
36. Schumann Burkard, G., Jutzi, P., and Roditi, I. (2011) Genome-wide
RNAi screens in bloodstream form trypanosomes identify drug trans-
porters. Mol. Biochem. Parasitol. 175, 91–94
37. Goldman-Pinkovich, A., Balno, C., Strasser, R., Zeituni-Molad, M.,
Bendelak, K., Rentsch, D., Ephros, M., Wiese, M., Jardim, A., Myler, P. J.,
and Zilberstein, D. (2016) An arginine deprivation response pathway is
induced in Leishmania during macrophage invasion. PLoS Pathog. 12,
e1005494
38. Aoki, J. I., Muxel, S. M., Zampieri, R. A., Acuña, S. M., Fernandes, J. C.
R., Vanderlinde, R. H., Sales, M. C. O. P., and Floeter-Winter, L. M.
(2017) L-arginine availability and arginase activity: Characterization of
amino acid permease 3 in Leishmania amazonensis. PLoS Negl. Trop.
Dis. 11, e0006025
39. Queiroz, R., Benz, C., Fellenberg, K., Hoheisel, J. D., andClayton, C. (2009)
Transcriptome analysis of differentiating trypanosomes reveals the exis-
tence of multiple post-transcriptional regulons. BMC Genomics 10, 495
40. Urbaniak, M. D., Guther, M. L. S., and Ferguson, M. A. J. (2012)
Comparative SILAC proteomic analysis of Trypanosoma brucei blood-
stream and procyclic lifecycle stages. PLoS One 7, e36619
41. Naguleswaran, A., Doiron, N., and Roditi, I. (2018) RNA-Seq analysis
validates the use of culture-derived Trypanosoma brucei and provides
new markers for mammalian and insect life-cycle stages. BMC Genomics
19, 227
42. Siegel, T. N., Hekstra, D. R., Wang, X., Dewell, S., and Cross, G. A. M.
(2010) Genome-wide analysis of mRNA abundance in two life-cycle
stages of Trypanosoma brucei and identification of splicing and poly-
adenylation sites. Nucleic Acids Res. 38, 4946–4957
43. Jensen, B. C., Ramasamy, G., Vasconcelos, E. J. R., Ingolia, N. T., Myler,
P. J., and Parsons, M. (2014) Extensive stage-regulation of translation
revealed by ribosome profiling of Trypanosoma brucei. BMC Genomics
15, 911
44. Vasquez, J.-J., Hon, C.-C., Vanselow, J. T., Schlosser, A., and Siegel, T. N.
(2014) Comparative ribosome profiling reveals extensive translational
complexity in different Trypanosoma brucei life cycle stages. Nucleic
Acids Res. 42, 3623–3637
45. Jensen, B. C., Sivam, D., Kifer, C. T., Myler, P. J., and Parsons, M. (2009)
Widespread variation in transcript abundance within and across devel-
opmental stages of Trypanosoma brucei. BMC Genomics 10, 482
46. Dejung, M., Subota, I., Bucerius, F., Dindar, G., Freiwald, A., Engstler,
M., Boshart, M., Butter, F., and Janzen, C. J. (2016) Quantitative pro-
teomics uncovers novel factors involved in developmental differentiation
of Trypanosoma brucei. PLoS Pathog. 12, e1005439
47. Jackson, A. P. (2007) Origins of amino acid transporter loci in trypa-
nosomatid parasites. BMC Evol. Biol. 7, 26
48. Wirtz, E., Leal, S., Ochatt, C., and Cross, G. A. (1999) A tightly regulated
inducible expression system for conditional gene knock-outs and
dominant-negative genetics in Trypanosoma brucei. Mol. Biochem.
Parasitol. 99, 89–101
49. Brun, R., and Schönenberger. (1979) Cultivation and in vitro cloning or
procyclic culture forms of Trypanosoma brucei in a semi-defined me-
dium. Short communication. Acta Trop. 36, 289–29250. Hirumi, H., and Hirumi, K. (1989) Continuous cultivation of Trypano-
soma brucei blood stream forms in a medium containing a low con-
centration of serum protein without feeder cell layers. J. Parasitol. 75,
985–989
51. Müller, L. S. M., Cosentino, R. O., Förstner, K. U., Guizetti, J., Wedel, C.,
Kaplan, N., Janzen, C. J., Arampatzi, P., Vogel, J., Steinbiss, S., Otto, T.
D., Saliba, A.-E., Sebra, R. P., and Siegel, T. N. (2018) Genome organi-
zation and DNA accessibility control antigenic variation in trypano-
somes. Nature 563, 121–125
52. Aslett, M., Aurrecoechea, C., Berriman, M., Brestelli, J., Brunk, B. P.,
Carrington, M., Depledge, D. P., Fischer, S., Gajria, B., Gao, X., Gardner,
M. J., Gingle, A., Grant, G., Harb, O. S., Heiges, M., et al. (2010) Tri-
TrypDB: A functional genomic resource for the trypanosomatidae.
Nucleic Acids Res. 38, D457–D462
53. Claros, M. G., and Vincens, P. (1996) Computational method to predict
mitochondrially imported proteins and their targeting sequences. Eur. J.
Biochem. 241, 779–786
54. Fukasawa, Y., Tsuji, J., Fu, S.-C., Tomii, K., Horton, P., and Imai, K.
(2015) MitoFates: Improved prediction of mitochondrial targeting se-
quences and their cleavage sites. Mol. Cell. Proteomics 14, 1113–1126
55. Almagro Armenteros, J. J., Salvatore, M., Emanuelsson, O., Winther, O.,
von Heijne, G., Elofsson, A., and Nielsen, H. (2019) Detecting sequence
signals in targeting peptides using deep learning. Life Sci. Alliance 2, 1–
14
56. Almagro Armenteros, J. J., Tsirigos, K. D., Sønderby, C. K., Petersen, T.
N., Winther, O., Brunak, S., von Heijne, G., and Nielsen, H. (2019)
SignalP 5.0 improves signal peptide predictions using deep neural net-
works. Nat. Biotechnol. 37, 420–423
57. Horton, P., Park, K.-J., Obayashi, T., Fujita, N., Harada, H., Adams-
Collier, C. J., and Nakai, K. (2007) WoLF PSORT: Protein localization
predictor. Nucleic Acids Res. 35, W585–W587
58. Güther, M. L. S., Urbaniak, M. D., Tavendale, A., Prescott, A., and
Ferguson, M. A. J. (2014) High-confidence glycosome proteome for
procyclic form Trypanosoma brucei by epitope-tag organelle enrich-
ment and SILAC proteomics. J. Proteome Res. 13, 2796–2806
59. Zíková, A., Verner, Z., Nenarokova, A., Michels, P. A. M., and Lukes, J.
(2017) A paradigm shift: The mitoproteomes of procyclic and blood-
stream Trypanosoma brucei are comparably complex. PLoS Pathog. 13,
e1006679
60. Bridges, D. J., Pitt, A. R., Hanrahan, O., Brennan, K., Voorheis, H. P.,
Herzyk, P., de Koning, H. P., and Burchmore, R. J. S. (2008) Charac-
terisation of the plasma membrane subproteome of bloodstream form
Trypanosoma brucei. Proteomics 8, 83–99
61. Oberholzer, M., Langousis, G., Nguyen, H. T., Saada, E. A., Shimogawa,
M. M., Jonsson, Z. O., Nguyen, S. M., Wohlschlegel, J. A., and Hill, K. L.
(2011) Independent analysis of the flagellum surface and matrix pro-
teomes provides insight into flagellum signaling in mammalian-
infectious Trypanosoma brucei. Mol. Cell. Proteomics 10. M111.010538
62. Subota, I., Julkowska, D., Vincensini, L., Reeg, N., Buisson, J., Blisnick, T.,
Huet, D., Perrot, S., Santi-Rocca, J., Duchateau, M., Hourdel, V., Rous-
selle, J.-C., Cayet, N., Namane, A., Chamot-Rooke, J., et al. (2014)
Proteomic analysis of intact flagella of procyclic Trypanosoma brucei
cells identifies novel flagellar proteins with unique sub-localization and
dynamics. Mol. Cell. Proteomics 13, 1769–1786
63. Dean, S., Sunter, J. D., and Wheeler, R. J. (2017) TrypTag.org: A
trypanosome genome-wide protein localisation resource. Trends Para-
sitol. 33, 80–82
64. Ariyanayagam, M. R., Oza, S. L., Guther, M. L. S., and Fairlamb, A. H.
(2005) Phenotypic analysis of trypanothione synthetase knockdown in
the African trypanosome. Biochem. J. 391, 425–432
65. Creek, D. J., Nijagal, B., Kim, D.-H., Rojas, F., Matthews, K. R., and
Barrett, M. P. (2013) Metabolomics guides rational development of a
simplified cell culture medium for drug screening against Trypanosoma
brucei. Antimicrob. Agents Chemother. 57, 2768–2779
66. Beneke, T., Madden, R., Makin, L., Valli, J., Sunter, J., and Gluenz, E.
(2017) A CRISPR Cas9 high-throughput genome editing toolkit for
kinetoplastids. R. Soc. Open Sci. 4, 170095J. Biol. Chem. (2021) 296 100566 19
EDITORS’ PICK: Proline/alanine transporters in T. brucei67. Rico, E., Jeacock, L., Kovárová, J., and Horn, D. (2018) Inducible high-
efficiency CRISPR-Cas9-targeted gene editing and precision base edit-
ing in African trypanosomes. Sci. Rep. 8, 1–10
68. Nilsson, D., Gunasekera, K., Mani, J., Osteras, M., Farinelli, L., Baer-
locher, L., Roditi, I., and Ochsenreiter, T. (2010) Spliced leader trapping
reveals widespread alternative splicing patterns in the highly dynamic
transcriptome of Trypanosoma brucei. PLoS Pathog. 6, 21–22
69. Rico, E., Rojas, F., Mony, B. M., Szoor, B., MacGregor, P., and Mat-
thews, K. R. (2013) Bloodstream form pre-adaptation to the tsetse fly in
Trypanosoma brucei. Front. Cell. Infect. Microbiol. 3, 78
70. Brown, R. C., Evans, D. A., and Vickerman, K. (1973) Changes in
oxidative metabolism and ultrastructure accompanying differentiation of
the mitochondrion in Trypanosoma brucei. Int. J. Parasitol. 3, 691–704
71. van Grinsven, K. W. A., Van Den Abbeele, J., Van den Bossche, P., van
Hellemond, J. J., and Tielens, A. G. M. (2009) Adaptations in the glucose
metabolism of procyclic Trypanosoma brucei isolates from tsetse flies
and during differentiation of bloodstream forms. Eukaryot. Cell. 8,
1307–1311
72. Kabani, S., Fenn, K., Ross, A., Ivens, A., Smith, T. K., Ghazal, P., and
Matthews, K. (2009) Genome-wide expression profiling of in vivo-
derived bloodstream parasite stages and dynamic analysis of mRNA
alterations during synchronous differentiation in Trypanosoma brucei.
BMC Genomics 10, 427
73. Engstler, M. (2004) Cold shock and regulation of surface protein traf-
ficking convey sensitization to inducers of stage differentiation in Try-
panosoma brucei. Genes Dev. 18, 2798–2811
74. Rolin, S., Hanocq-Quertier, J., Paturiaux-Hanocq, F., Nolan, D. P., and
Pays, E. (1998) Mild acid stress as a differentiation trigger in Trypano-
soma brucei. Mol. Biochem. Parasitol. 93, 251–262
75. Sbicego, S., Vassella, E., Kurath, U., Blum, B., and Roditi, I. (1999) The
use of transgenic Trypanosoma brucei to identify compounds inducing
the differentiation of bloodstream forms to procyclic forms. Mol. Bio-
chem. Parasitol. 104, 311–322
76. Szöőr, B., Silvester, E., and Matthews, K. R. (2020) A leap into the un-
known – early events in African trypanosome transmission. Trends
Parasitol. 36, 266–278
77. Haanstra, J. R., Kerkhoven, E. J., van Tuijl, A., Blits, M., Wurst, M., van
Nuland, R., Albert, M., Michels, P. A. M., Bouwman, J., Clayton, C.,
Westerhoff, H. V., and Bakker, B. M. (2011) A domino effect in drug
action: From metabolic assault towards parasite differentiation. Mol.
Microbiol. 79, 94–108
78. Zoltner, M., Campagnaro, G. D., Taleva, G., Burrell, A., Cerone, M.,
Leung, K., Achcar, F., Horn, D., Vaughan, S., Gadelha, C., Zíková, A.,
Barrett, M. P., de Koning, H. P., and Field, M. C. (2020) Suramin
exposure alters cellular metabolism and mitochondrial energy produc-
tion in African trypanosomes. J. Biol. Chem. 295, 8331–8347
79. Cunningham, I., and Slater, J. S. (1974) Amino acid analyses of hae-
molymph of Glossina morsitans morsitans (Westwood). Acta Trop. 31,
83–88
80. Hargrove, J. W. (1976) Amino acid metabolism during flight in tsetse
flies. J. Insect Physiol. 22, 309–313
81. Savage, A. F., Kolev, N. G., Franklin, J. B., Vigneron, A., Aksoy, S., and
Tschudi, C. (2016) Transcriptome profiling of trypanosoma brucei
development in the tsetse fly vector Glossina morsitans. PLoS One 11,
e0168877
82. Williamson, J. (1956) The composition of tsetse-fly saliva. II. Analysis of
amino acids and sugars by paper partition chromatography. Ann. Trop.
Med. Parasitol. 50, 334–344
83. Patel, N. Y., Youdeowei, A., and Odhiambo, T. R. (1981) The compo-
sition of the salivary gland secretion of the tsetse, Glossina morsitans
morsitans Westwood 1850 (Diptera: Glossinidae). Int. J. Trop. Insect Sci.
1, 383–387
84. Van Den Abbeele, J., Caljon, G., De Ridder, K., De Baetselier, P., and
Coosemans, M. (2010) Trypanosoma brucei modifies the tsetse salivary
composition, altering the fly feeding behavior that favors parasite
transmission. PLoS Pathog. 6, e1000926
85. Vigneron, A., O’Neill, M. B., Weiss, B. L., Savage, A. F., Campbell, O. C.,
Kamhawi, S., Valenzuela, J. G., and Aksoy, S. (2020) Single-cell RNA20 J. Biol. Chem. (2021) 296 100566sequencing of Trypanosoma brucei from tsetse salivary glands unveils
metacyclogenesis and identifies potential transmission blocking antigens.
Proc. Natl. Acad. Sci. U. S. A. 117, 2613–2621
86. Royle, S. J., and Murrell-Lagnado, R. D. (2003) Constitutive cycling: A
general mechanism to regulate cell surface proteins. Bioessays 25, 39–46
87. Ghaddar, K., Merhi, A., Saliba, E., Krammer, E.-M., Prévost, M., and
André, B. (2014) Substrate-induced ubiquitylation and endocytosis of
yeast amino acid permeases. Mol. Cell. Biol. 34, 4447–4463
88. L’Hostis, C., Geindre, M., and Deshusses, J. (1993) Active transport of L-
proline in the protozoan parasite Trypanosoma brucei brucei. Biochem.
J. 291(Pt 1), 297–301
89. Silber, A. M., Tonelli, R. R., Martinelli, M., Colli, W., and Alves, M. J. M.
(2002) Active transport of L-proline in Trypanosoma cruzi. J. Eukaryot.
Microbiol. 49, 441–446
90. Mazareb, S., Fu, Z. Y., and Zilberstein, D. (1999) Developmental regu-
lation of proline transport in Leishmania donovani. Exp. Parasitol. 91,
341–348
91. Schlisselberg, D., Mazarib, E., Inbar, E., Rentsch, D., Myler, P. J., and
Zilberstein, D. (2015) Size does matter: 18 amino acids at the N-terminal
tip of an amino acid transporter in Leishmania determine substrate
specificity. Sci. Rep. 5, 16289
92. Chappell, L. H., Southworth, G. C., and Read, C. P. (1972) Short-interval
absorption and metabolism of some amino acids in Trypanosoma
gambiense. Parasitology 64, 379–387
93. Simon, M. W., Jayasimhulu, K., and Mukkada, A. J. (1983) The free
amino acid pool in Leishmania tropica promastigotes. Mol. Biochem.
Parasitol. 9, 47–57
94. Kim, D.-H., Achcar, F., Breitling, R., Burgess, K. E., and Barrett, M. P.
(2015) LC-MS-based absolute metabolite quantification: Application to
metabolic flux measurement in trypanosomes. Metabolomics 11, 1721–
1732
95. Mazet, M., Morand, P., Biran, M., Bouyssou, G., Courtois, P., Dau-
louède, S., Millerioux, Y., Franconi, J.-M., Vincendeau, P., Moreau, P.,
and Bringaud, F. (2013) Revisiting the central metabolism of the
bloodstream forms of trypanosoma brucei: Production of acetate in the
mitochondrion is essential for parasite viability. PLoS Negl. Trop. Dis. 7,
e2587
96. Girard, R. M. B. M., Crispim, M., Alencar, M. B., and Silber, A. M.
(2018) Uptake of l-alanine and its distinct roles in the bioenergetics of
trypanosoma cruzi. mSphere 3. e00338-18
97. Isoun, T. T., and Isoun, M. J. (1978) Free plasma amino acid profiles of
normal and Trypanosoma brucei-infected rats. Acta Trop. 35, 287–290
98. Newport, G. R., Page, C. R., Ashman, P. U., Stibbs, H. H., and Seed, J. R.
(1977) Alteration of free serum amino acids in voles infected with try-
panosoma brucei gambiense. J. Parasitol. 63, 15
99. Rentsch, D., Laloi, M., Rouhara, I., Schmelzer, E., Delrot, S., and
Frommer, W. B. (1995) NTR1 encodes a high affinity oligopeptide
transporter in Arabidopsis. FEBS Lett. 370, 264–268
100. Wang, Z., Morris, J. C., Drew, M. E., and Englund, P. T. (2000) Inhi-
bition of Trypanosoma brucei gene expression by RNA interference
using an integratable vector with opposing T7 promoters. J. Biol. Chem.
275, 40174–40179
101. Mani, J., Desy, S., Niemann, M., Chanfon, A., Oeljeklaus, S., Pusnik, M.,
Schmidt, O., Gerbeth, C., Meisinger, C., Warscheid, B., and Schneider,
A. (2015) Mitochondrial protein import receptors in Kinetoplastids
reveal convergent evolution over large phylogenetic distances. Nat.
Commun. 6, 6646
102. Dohmen, R. J., Strasser, A. W., Höner, C. B., and Hollenberg, C. P.
(1991) An efficient transformation procedure enabling long-term stor-
age of competent cells of various yeast genera. Yeast 7, 691–692
103. Hein, C., and André, B. (1997) A C-terminal di-leucine motif and nearby
sequences are required for NH 4 + -induced inactivation and degrada-
tion of the general amino acid permease, Gap1p, of Saccharomyces
cerevisiae. Mol. Microbiol. 24, 607–616
104. Jauniaux, J. C., Vandenbol, M., Vissers, S., Broman, K., and Grenson, M.
(1987) Nitrogen catabolite regulation of proline permease in Saccharo-
myces cerevisiae. Cloning of the PUT4 gene and study of PUT4 RNA
levels in wild-type and mutant strains. Eur. J. Biochem. 164, 601–606
EDITORS’ PICK: Proline/alanine transporters in T. brucei105. Fischer, W.-N., Loo, D. D. F., Koch, W., Ludewig, U., Boorer, K. J.,
Tegeder, M., Rentsch, D., Wright, E. M., and Frommer, W. B. (2002)
Low and high affinity amino acid H+-cotransporters for cellular import
of neutral and charged amino acids. Plant J. 29, 717–731
106. Tanaka, J., and Fink, G. R. (1985) The histidine permease gene (HIP1) of
Saccharomyces cerevisiae. Gene 38, 205–214
107. Shaked-Mishan, P., Suter-Grotemeyer, M., Yoel-Almagor, T., Holland,
N., Zilberstein, D., and Rentsch, D. (2006) A novel high-affinity arginine
transporter from the human parasitic protozoan Leishmania donovani.
Mol. Microbiol. 60, 30–38
108. Jacobs, P., Jauniaux, J. C., and Grenson, M. (1980) A cis-dominant
regulatory mutation linked to the argB-argC gene cluster in Saccharo-
myces cerevisiae. J. Mol. Biol. 139, 691–704
109. Sherman, F. (2002) Getting started with yeast. Methods Enzymol. 350,
3–41
110. Meyer, A., Eskandari, S., Grallath, S., and Rentsch, D. (2006) AtGAT1, a
high affinity transporter for gamma-aminobutyric acid in Arabidopsis
thaliana. J. Biol. Chem. 281, 7197–7204
111. Kaur, J., and Bachhawat, A. K. (2007) Yct1p, a novel, high-affinity,
cysteine-specific transporter from the yeast Saccharomyces cerevisiae.
Genetics 176, 877–890
112. Kwart, M., Hirner, B., Hummel, S., and Frommer, W. B. (1993) Dif-
ferential expression of two related amino acid transporters with differing
substrate specificity in Arabidopsis thaliana. Plant J. 4, 993–1002
113. Rentsch, D., Hirner, B., Schmelzer, E., and Frommer, W. B. (1996) Salt
stress-induced proline transporters and salt stress-repressed broad
specificity amino acid permeases identified by suppression of a yeast
amino acid permease-targeting mutant. Plant Cell 8, 1437–1446
114. Peng, D., and Tarleton, R. (2015) EuPaGDT: A web tool tailored to
design CRISPR guide RNAs for eukaryotic pathogens. Microb. Geno-
mics. 1, 1–7
115. Dean, S., Sunter, J., Wheeler, R. J., Hodkinson, I., Gluenz, E., Gull, K.,
and Dean, S. (2015) A toolkit enabling efficient , scalable and repro-
ducible gene tagging in trypanosomatids. Open Biol. 5, 140197116. Chomczynski, P., and Sacchi, N. (1987) Single-step method of RNA
isolation by acid guanidinium thiocyanate-phenol-chloroform extrac-
tion. Anal. Biochem. 162, 156–159
117. Langmead, B., Trapnell, C., Pop, M., and Salzberg, S. L. (2009) Ultrafast
and memory-efficient alignment of short DNA sequences to the human
genome. Genome Biol. 10, R25
118. Afgan, E., Baker, D., Batut, B., van den Beek, M., Bouvier, D., Cech, M.,
Chilton, J., Clements, D., Coraor, N., Grüning, B. A., Guerler, A., Hill-
man-Jackson, J., Hiltemann, S., Jalili, V., Rasche, H., et al. (2018) The
galaxy platform for accessible, reproducible and collaborative biomedical
analyses: 2018 update. Nucleic Acids Res. 46, W537–W544
119. Li, L., Stoeckert, C. J., and Roos, D. S. (2003) OrthoMCL: Identification
of ortholog groups for eukaryotic genomes. Genome Res. 13, 2178–
2189
120. Brenndörfer, M., and Boshart, M. (2010) Selection of reference genes for
mRNA quantification in Trypanosoma brucei. Mol. Biochem. Parasitol.
172, 52–55
121. Jones, N. G., Thomas, E. B., Brown, E., Dickens, N. J., Hammarton, T. C.,
and Mottram, J. C. (2014) Regulators of Trypanosoma brucei cell cycle
progression and differentiation identified using a kinome-wide RNAi
screen. PLoS Pathog. 10, e1003886
122. t’Kindt, R., Jankevics, A., Scheltema, R. A., Zheng, L., Watson, D. G.,
Dujardin, J.-C., Breitling, R., Coombs, G. H., and Decuypere, S. (2010)
Towards an unbiased metabolic profiling of protozoan parasites: Opti-
misation of a Leishmania sampling protocol for HILIC-orbitrap analysis.
Anal. Bioanal. Chem. 398, 2059–2069
123. Bidlingmeyer, B. A., Cohen, S. A., and Tarvin, T. L. (1984) Rapid analysis
of amino acids using pre-column derivatization. J. Chromatogr. 336, 93–
104
124. Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M.,
Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., Tinevez,
J.-Y., White, D. J., Hartenstein, V., Eliceiri, K., Tomancak, P., et al. (2012)
Fiji: An open-source platform for biological-image analysis. Nat.
Methods 9, 676–682Alexander C. Haindrich recently completed his PhD at the University of Bern. He is fascinated by the metabolism and life cycle
of the protozoan parasite Trypanosoma brucei. Alex’s research focuses on how the parasite regulates amino acid transporters in
response to changes in nutrients. These are encountered when trypanosomes change the host or invade different host tissues
and can impact on growth, development, and pathogenicity.J. Biol. Chem. (2021) 296 100566 21
